<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Subst Abuse Rehabil</journal-id><journal-id journal-id-type="iso-abbrev">Subst Abuse Rehabil</journal-id><journal-id journal-id-type="pmc-domain-id">2178</journal-id><journal-id journal-id-type="pmc-domain">sar</journal-id><journal-id journal-id-type="publisher-id">sar</journal-id><journal-title-group><journal-title>Substance Abuse and Rehabilitation</journal-title></journal-title-group><issn pub-type="epub">1179-8467</issn><publisher><publisher-name>Dove Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10351681</article-id><article-id pub-id-type="pmcid-ver">PMC10351681.1</article-id><article-id pub-id-type="pmcaid">10351681</article-id><article-id pub-id-type="pmcaiid">10351681</article-id><article-id pub-id-type="pmid">37465017</article-id><article-id pub-id-type="doi">10.2147/SAR.S376389</article-id><article-id pub-id-type="publisher-id">376389</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>A Prospective Biopsychosocial Repeated Measures Study of Stress and Dropout from Substance Addiction Treatment</article-title><alt-title alt-title-type="running-authors">B&#248;hle et al</alt-title><alt-title alt-title-type="running-title">B&#248;hle et al</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-7187-4010</contrib-id><name name-style="western"><surname>B&#248;hle</surname><given-names initials="K">Kari</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="an0001" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Otterholt</surname><given-names initials="E">Eli</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-7523-1757</contrib-id><name name-style="western"><surname>Bj&#248;rkly</surname><given-names initials="SK">St&#229;l Kapst&#248;</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><aff id="aff0001"><label>1</label><institution>Faculty of Health and Social Science, Molde University College</institution>, <addr-line>Molde</addr-line>, <country>Norway</country></aff><aff id="aff0002"><label>2</label><institution>Clinic of Mental Health and Addiction, M&#248;re and Romsdal Hospital Trust</institution>, <addr-line>Molde</addr-line>, <country>Norway</country></aff><aff id="aff0003"><label>3</label><institution>Department of Mental Health, Norwegian University of Science and Technology</institution>, <addr-line>Trondheim</addr-line>, <country>Norway</country></aff><aff id="aff0004"><label>4</label><institution>Regional Centre for Research and Education in Forensic Psychiatry, Oslo University Hospital</institution>, <addr-line>Oslo</addr-line>, <country>Norway</country></aff></contrib-group><author-notes><corresp id="an0001">Correspondence: Kari B&#248;hle, <institution>Molde University College</institution>, <addr-line>Britvegen 2</addr-line>, <addr-line>Molde</addr-line>, <addr-line>6412</addr-line>, <country>Norway</country>, <phone>Tel +47 911 09 321</phone>; <phone>+47 71 21 40 00</phone>, Email kari.bohle@ntnu.no</corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>7</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>14</volume><issue-id pub-id-type="pmc-issue-id">429601</issue-id><fpage>61</fpage><lpage>75</lpage><history><date date-type="received"><day>07</day><month>6</month><year>2022</year></date><date date-type="accepted"><day>02</day><month>5</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>13</day><month>07</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>18</day><month>07</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-07-19 11:25:10.247"><day>19</day><month>07</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; 2023 B&#248;hle et al.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>B&#248;hle et al.</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref><license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution &#8211; Non Commercial (unported, v3.0) License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="sar-14-61.pdf"/><abstract><sec sec-type="intro"><title>Introduction</title><p>This prospective, repeated-measures observational study tested biopsychosocial variables as risk factors for dropping out of inpatient substance addiction treatment. Substance use disorder (SUD) is viewed as a chronic relapsing disease caused by an interaction between biological, psychological, and social factors. However, there is a lack of prospective studies that combine biopsychosocial variables when assessing dropout. The aims of this study were to investigate whether there was 1) An association between biopsychosocial factors and dropping out of inpatient substance addiction treatment, 2) An interaction with SUD diagnosis and cortisol, and 3) Different dropout rates between short-term and long-term institutions.</p></sec><sec><title>Materials and Methods</title><p>Patients (n = 173) were recruited from two inpatient treatment centers in Norway between 2018 and 2021. The following biopsychosocial variables were measured at four timepoints: ward atmosphere (Ward Atmosphere Scale, WAS), psychological distress (Hopkins Symptom Checklist 10, HSCL-10), motivation (M-scale of the Circumstances, Motivation, Readiness, and Suitability questionnaire), and concentration of salivary cortisol (CORT- nmol/L). Cortisol levels were measured for two consecutive days at each timepoint and calculated by two cortisol indices, daytime cortisol slope (DCS) and area under the curve with respect to the ground (AUC<sub>G</sub>). A multivariate logistic regression analysis was performed to find an association between dropout rates and the biopsychosocial variables.</p></sec><sec><title>Results</title><p>The results suggest a lower dropout odds for patients with high motivation (OR = 0.76, p = 0.022) and patients admitted to short-term treatment (OR = 0.06, p = 0.005). An interaction with stimulant SUD and DCS (OR = 13.74, p = 0.024) also revealed higher dropout odds. No statistical significance was found for psychological distress, WAS, and cortisol AUC<sub>G</sub>.</p></sec><sec><title>Conclusion</title><p>The results support monitoring motivation during treatment and further investigating biopsychosocial variables when assessing dropout risk together with SUD diagnosis.</p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>cortisol</kwd><kwd>psychological distress</kwd><kwd>ward atmosphere</kwd><kwd>retention</kwd><kwd>drug abstinence</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>the Liaison Committee for Education</institution></institution-wrap></funding-source></award-group><award-group><funding-source><institution-wrap><institution>Research and Innovation in Central Norway</institution></institution-wrap></funding-source></award-group><funding-statement>The study was funded by the Liaison Committee for Education (46055500-23), Research and Innovation in Central Norway.</funding-statement></funding-group><counts><fig-count count="0"/><table-count count="4"/><ref-count count="99"/><page-count count="15"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s0001"><title>Introduction</title><p>Retention and completion of SUD -programs are associated with positive treatment outcomes.<xref rid="cit0001" ref-type="bibr">1</xref>,<xref rid="cit0002" ref-type="bibr">2</xref> A Norwegian study of treatment effect in five residential treatment facilities found that relapse occurred among 37% of the sample three-month after submission.<xref rid="cit0002" ref-type="bibr">2</xref> Studies of patients receiving treatment in therapeutic community-based programs have shown significant improvements, including 50% reduction in prevalence of weekly or daily cocaine use at 5 years follow up compared to the year before entering treatment.<xref rid="cit0003" ref-type="bibr">3</xref> Even though systematic reviews show reduction in substance abuse during treatment, the effect on a longer time perspective is unclear.<xref rid="cit0001" ref-type="bibr">1</xref>,<xref rid="cit0004" ref-type="bibr">4</xref> Meta-analyses of Cognitive Behavioral Therapy (CBT) based treatment of SUD have also revealed significant effects in terms of quantity and frequency of alcohol and drug use.<xref rid="cit0005" ref-type="bibr">5</xref> Compared to untreated or minimally treated control groups, CBT had up to 26% better outcomes.<xref rid="cit0005" ref-type="bibr">5</xref>,<xref rid="cit0006" ref-type="bibr">6</xref> Research on the important association between successful prison addiction programs and desistance from crime has also been found.<xref rid="cit0007" ref-type="bibr">7</xref>,<xref rid="cit0008" ref-type="bibr">8</xref></p><p>Dropping out of substance addiction treatment is considered a major challenge in the field of substance addiction research.<xref rid="cit0002" ref-type="bibr">2</xref>,<xref rid="cit0009" ref-type="bibr">9</xref> Studies have tried to identify the risk factors of dropout, but the only consistent risk factor that they have identified is being a younger age.<xref rid="cit0010" ref-type="bibr">10&#8211;18</xref> Research on dropout has primarily focused on pre-treatment factors, such as demographic and patient-related factors.<xref rid="cit0017" ref-type="bibr">17</xref>,<xref rid="cit0019" ref-type="bibr">19</xref> Instruments for monitoring individual treatment processes have been developed over the past several decades, and one of the reported benefits of using these tools for monitoring is reduced dropout.<xref rid="cit0020" ref-type="bibr">20&#8211;22</xref> However, we lack empirical evidence that proves these systems can predict dropout.<xref rid="cit0019" ref-type="bibr">19</xref> Dropout rates are still relatively high, and studies that focus on factors that can be assessed during treatment while investigating risk factors for dropout are necessary.<xref rid="cit0010" ref-type="bibr">10</xref>,<xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0013" ref-type="bibr">13</xref>,<xref rid="cit0017" ref-type="bibr">17</xref>,<xref rid="cit0019" ref-type="bibr">19</xref></p><p>Although several studies have investigated individual factors connected to dropout from substance addiction treatment, the literature is dispersed across various disciplines and foci. This study seeks to bridge the gap in research by examining how multiple factors affect the odds of dropping out of treatment. Specifically, we draw upon the biopsychosocial model of addiction, which views substance addiction as a chronic relapsing disease caused by an interaction between biological, social, and psychological factors.<xref rid="cit0023" ref-type="bibr">23&#8211;26</xref> Developments that have been made in the SUD research field over the past few decades have provided a growing body of evidence that shows biological factors, such as cortisol, predict dropout from substance addiction treatment.<xref rid="cit0009" ref-type="bibr">9</xref>,<xref rid="cit0027" ref-type="bibr">27</xref>,<xref rid="cit0028" ref-type="bibr">28</xref> Psychosocial variables, such as psychological distress and perceptions of the therapeutic milieu, have also been linked to dropout.<xref rid="cit0029" ref-type="bibr">29</xref> However, few studies use the biopsychosocial model when assessing dropout risk.</p><p>Abnormal cortisol levels have been found to be associated with mental disorders, and normalization of secretion patterns are important for recovery.<xref rid="cit0030" ref-type="bibr">30</xref> Salivary cortisol is released in response to stress and is viewed as a possible marker that an individual is vulnerable to substance addiction and relapse.<xref rid="cit0031" ref-type="bibr">31&#8211;35</xref> There is also assumed to be a reciprocal relationship between cortisol, emotions and behavior that influences vulnerability to addiction and relapse in individuals with SUD.<xref rid="cit0036" ref-type="bibr">36</xref>,<xref rid="cit0037" ref-type="bibr">37</xref> However, the results from research on cortisol have provided conflicting results.<xref rid="cit0009" ref-type="bibr">9</xref>,<xref rid="cit0027" ref-type="bibr">27</xref>,<xref rid="cit0037" ref-type="bibr">37</xref>,<xref rid="cit0038" ref-type="bibr">38</xref> There is thus a need for prospective studies that take psychosocial variables into account when assessing dropout risk.<xref rid="cit0037" ref-type="bibr">37&#8211;39</xref></p><p>Studies assessing salivary cortisol in the SUD population have shown disparate results in predicting dropout. Research has shown both higher and lower cortisol levels and HPA-activation in the SUD population.<xref rid="cit0009" ref-type="bibr">9</xref>,<xref rid="cit0027" ref-type="bibr">27</xref>,<xref rid="cit0040" ref-type="bibr">40&#8211;44</xref> These findings are comparable with studies on HPA-axis functioning in individuals with psychiatric disorders, where both hypo- and hypercortisolism have been associated with aggression, depression, and behavioral issues.<xref rid="cit0045" ref-type="bibr">45</xref>,<xref rid="cit0046" ref-type="bibr">46</xref> Findings point to both differences in cortisol response depending on the substance being used and variety in the same SUD group, which could be explained by different study designs, phases of withdrawal, or interacting psychosocial variables.<xref rid="cit0042" ref-type="bibr">42</xref>,<xref rid="cit0044" ref-type="bibr">44</xref>,<xref rid="cit0047" ref-type="bibr">47&#8211;49</xref> Normalization of cortisol levels during recovery has been reported in both individuals with alcohol dependency<xref rid="cit0050" ref-type="bibr">50</xref> and opioid dependency.<xref rid="cit0051" ref-type="bibr">51</xref> A limitation of previous research is the lack of repeated measures and a standardized protocol for sampling and calculation of salivary cortisol measures. Of the few prospective studies,<xref rid="cit0027" ref-type="bibr">27</xref>,<xref rid="cit0038" ref-type="bibr">38</xref>,<xref rid="cit0042" ref-type="bibr">42</xref>,<xref rid="cit0052" ref-type="bibr">52</xref> a study conducted by Jaremko et al<xref rid="cit0038" ref-type="bibr">38</xref> is of special interest due to the fact that it combined biological and psychosocial variables when assessing dropout risk. This study found that abnormal cortisol measures increased dropout risk and elevated psychological distress and poor treatment engagement in those who dropped out.<xref rid="cit0038" ref-type="bibr">38</xref></p><p>The relationship between psychological factors and substance addiction is well documented. More than 50% of individuals with a SUD will experience mental health illness during their lifetime.<xref rid="cit0053" ref-type="bibr">53</xref>,<xref rid="cit0054" ref-type="bibr">54</xref> The co-occurrence between psychiatric disorders and SUD might be rooted in a shared genetic vulnerability, or it could be that mental illness might be the reason for substance use or vice versa.<xref rid="cit0055" ref-type="bibr">55</xref>,<xref rid="cit0056" ref-type="bibr">56</xref> A higher substance use relapse rate has been found in individuals with SUD who also have a co-occurring psychiatric disorder.<xref rid="cit0057" ref-type="bibr">57</xref></p><p>Recent research points to psychological factors and psychological distress as important factors in predicting dropout.<xref rid="cit0016" ref-type="bibr">16</xref>,<xref rid="cit0058" ref-type="bibr">58&#8211;61</xref> Research has found associations between psychological stress and retention through the use of questionnaires that capture stress levels, such as the Symptom of Stress<xref rid="cit0058" ref-type="bibr">58</xref> inventory and Hopkins Symptom Checklist.<xref rid="cit0054" ref-type="bibr">54</xref>,<xref rid="cit0058" ref-type="bibr">58</xref>,<xref rid="cit0059" ref-type="bibr">59</xref> In a study from 2021,<xref rid="cit0060" ref-type="bibr">60</xref> Ormbostad et al investigated whether dropout was a deliberate or impulsive act. They found that patients who dropped out of treatment had high levels of emotional distress and reported difficulty with program-related factors, such as rules and limit-setting. The treatment-related factors that patients reported as being difficult included group therapy, the work structure, sharing accommodations with other patients, and not having access to clinical staff.<xref rid="cit0060" ref-type="bibr">60</xref></p><p>In residential treatment of SUD, the social environment with the other patients and the staff is an important part of the treatment process. Studies point to both the therapeutic alliance<xref rid="cit0057" ref-type="bibr">57</xref> and the therapeutic environment<xref rid="cit0062" ref-type="bibr">62&#8211;64</xref> as important factors for treatment retention. Positive identification and affiliation with the social environment during the first weeks in treatment also seem to be central for retention.<xref rid="cit0065" ref-type="bibr">65</xref> The Ward Atmosphere Scale (WAS<xref rid="cit0065" ref-type="bibr">65</xref>) is a questionnaire developed to capture perceptions of the therapeutic environment at inpatient clinics. The WAS has been useful in predicting retention in mental health settings,<xref rid="cit0062" ref-type="bibr">62</xref> and it has been found that patients who report less favorable perceptions of the ward atmosphere have a higher dropout risk.<xref rid="cit0066" ref-type="bibr">66</xref>,<xref rid="cit0067" ref-type="bibr">67</xref> Lower levels of perceived support from staff predicted dropout from substance addiction treatment in a study from 2006,<xref rid="cit0068" ref-type="bibr">68</xref> and Carr et al<xref rid="cit0062" ref-type="bibr">62</xref> found that heightened perceptions of orderliness (one of the domains in WAS) predicted retention in a therapeutic community residential clinic for substance addiction. Another study found that patients who were considered to be at high risk of dropping out seemed to profit in a therapeutic environment characterized by a high degree of support but low control.<xref rid="cit0068" ref-type="bibr">68</xref> Satisfaction with treatment has also been shown to be positively associated with treatment completion.<xref rid="cit0068" ref-type="bibr">68</xref>,<xref rid="cit0069" ref-type="bibr">69</xref> Patients who report lower levels of satisfaction have been found to be 2.5 times more likely to drop out.<xref rid="cit0069" ref-type="bibr">69</xref> This is in line with the Risk-Need-Responsivity model, and especially the matching concept where the patient&#8217;s social and psychological needs are determinants of which program the patient should attend.<xref rid="cit0070" ref-type="bibr">70</xref> Furthermore, matching seems important for treatment outcome. For instance, Stallvik et al<xref rid="cit0071" ref-type="bibr">71</xref> found that matching patients with SUD to optimal care level by using the American Society of Addiction Medicine (ASAM) -criteria significantly reduced alcohol and cannabis use after 3 months in treatment. ASAM is based on measure of addiction severity, as well as psychosocial factors. The literature regarding dropout rates and treatment dose seems to be somewhat mixed. Even though it is well established that treatment retention and engagement is associated with positive treatment outcomes,<xref rid="cit0010" ref-type="bibr">10</xref>,<xref rid="cit0038" ref-type="bibr">38</xref> studies have found that programs characterized by more and longer treatment sessions have a higher dropout rate.<xref rid="cit0072" ref-type="bibr">72</xref></p><p>A lack of proper motivation has often been used to explain why individuals fail to attend or complete treatment for substance addiction,<xref rid="cit0073" ref-type="bibr">73</xref> and higher motivation has been found to be significant in predicting treatment retention.<xref rid="cit0016" ref-type="bibr">16</xref>,<xref rid="cit0040" ref-type="bibr">40</xref>,<xref rid="cit0074" ref-type="bibr">74</xref>,<xref rid="cit0075" ref-type="bibr">75</xref> In a four-scale instrument called Circumstances, Readiness for Treatment, and Suitability for the Treatment Program (CMRS), motivation is treated as multidimensional and operationalized. In a study from 1998, Joe et al<xref rid="cit0076" ref-type="bibr">76</xref> found that pre-treatment motivation was positively associated with retention for individuals in substance addiction treatment, as the readiness modality was the strongest predictor of retention. In a more recent study, motivation was found to interact with distress tolerance in predicting retention. Higher motivation scores increased the likelihood of retention in individuals with high distress tolerance.<xref rid="cit0077" ref-type="bibr">77</xref></p><p>In general, findings from the literature suggest that there could be both biological and psychosocial risk factors for dropping out of substance addiction treatment. However, to the best of our knowledge prospective studies with repeated measures of a combination of biopsychosocial variables seem to be lacking. The present study aims to fill this gap in the literature by prospectively examining the combination of biological, psychological and social predictors of treatment dropout from residential addiction treatment. The development of biopsychosocial factors during the course of treatment may have important clinical implications and could help identify areas for improvement in clinical services.</p><p>This study aimed to investigate if there is 1) an association between biopsychosocial factors and dropping out from inpatient substance addiction treatment, 2) an interaction with SUD diagnosis and cortisol, and 3) different dropout rates between short-term and long-term institutions.</p></sec><sec id="s0002"><title>Method</title><sec id="s0002-s2001"><title>Study Design and Setting</title><p>This prospective observational study was conducted in a cohort of patients admitted to substance addiction treatment. Two residential units in the middle region of Norway participated in the study. Both units offered inpatient treatment for substance addiction. One was a short-term (2 months) clinic, and the other was long-term (6 months). The number of available treatment beds was 24 (short-term) and 15 (long-term) in 2020. A multidisciplinary treatment is offered in these units with a combination of individual, group, and milieu therapy. The staff members come from a range of disciplinary backgrounds and consist of social workers, psychologists, psychiatrists, doctors, nurses, physical therapists, and other trained or untrained staff. Patients can also participate in physical activities and training as part of their treatment or in their leisure time. The main goal of the treatment is to improve individual coping and overall functioning, and individual adjustments are tailored if necessary.</p><p>The long-term treatment (6 months) also follows a specific treatment structure and philosophy. The long-term clinic is categorized as a modified therapeutic community (TC).<xref rid="cit0077" ref-type="bibr">77</xref> The program is organized into 3 steps where the patient takes on more responsibility and is exposed to different roles and interactions with each step. A fundamental element of TS is social learning as the therapy is based on &#8220;community as a method&#8221;. The days are structured with work assessment, daily meetings and group treatment, and the program is meant to facilitate patient interactions with staff and other patients. Taking an active part in their own treatment and the treatment of other patients is considered to be a core concept of the program, as is milieu therapy that targets naturally occurring situations in the clinic.</p></sec><sec id="s0002-s2002"><title>Recruitment and Study Participants</title><p>The only inclusion criteria for participating in the study was admission. Exclusion criteria included being admitted involuntary or only admitted for a shorter period (&lt; 2 months). Patients who were judged to be mentally or physically incapable of giving consent on the day of data collection (assessment by the clinical staff) were also excluded from the study. According to the execution of the sentence act, &#167;12 is considered voluntary treatment, and individuals in this category were asked to participate. The &#167;12 law provides the opportunity for criminal proceedings to take place in an approved inpatient treatment facility for SUD. The treatment centers only offer treatment to people above 18 years old, so all study participants were adults.</p><p>Patients were sought out by the first author (K.B.) or one of the research assistants during their first week in treatment and asked to participate in the study. Both oral and written information was given before they signed the form confirming informed consent. Patients could either sign right away or take a few days to think about their decision. Patients who handed in questionnaires for each timepoint received a gift card of 300NOK at the last timepoint as an incentive for participating in the study.</p><p>Data were collected consecutively during the treatment stay for each participant, with measures collected every other week for 8 weeks. The first timepoint was in treatment week 2, and the 4th was in treatment week 8. Salivary cortisol, motivation, and psychological distress were measured at each timepoint. The WAS (Ward atmosphere scale) was included at timepoint 2 because the participants could not assess the ward atmosphere before they had experienced it.</p></sec><sec id="s0002-s2003"><title>Measures</title><p>A comprehensive questionnaire was developed for each timepoint (T1-4) and included validated instruments of ward atmosphere, motivation, and psychological distress. A sociodemographic form developed for this study was also used to collect information about background variables (T1). Salivary cortisol was collected at all timepoints (T1-4). The data collection period was from June 2018 to October 2021. Due to the COVID-19 pandemic, data collection was placed on hold from March to September 2020, and procedures for collection of salivary cortisol were adapted according to the Norwegian government&#8217;s COVID-19 measures.</p><sec id="s0002-s2003-s3001"><title>Dropout</title><p>Dropout was defined as discontinuation of the treatment according to the treatment plan. Dropout status (yes/no) was retrieved from the patient record for each timepoint (T1-4).</p></sec><sec id="s0002-s2003-s3002"><title>SUD and Other Diagnoses</title><p>Primary SUD and psychiatric diagnoses according to the International Classification of Diseases (ICD-10, World Health Organization<xref rid="cit0075" ref-type="bibr">75</xref>) were obtained from the patient record. SUD diagnoses were used as categorical variables, while psychiatric diagnoses were registered with number of diagnoses (number of psychiatric diagnoses).</p></sec><sec id="s0002-s2003-s3003"><title>Sociodemographic Form</title><p>The sociodemographic form developed for this study obtained information about age, sex, substance use history, &#167;12 status, and previous inpatient stays. The form was handed out at T1. The form was structured with predefined response options, except for age and years of substance use. Age and years of substance use was assessed and coded in years, and the options for gender were male and female. For &#167;12 status, the answer was either yes or no to the question of whether they were admitted according to &#167;12 now. The patients were also asked how many times they had been admitted to inpatient substance addiction treatment prior to their current stay, with predefined response alternatives.</p></sec><sec id="s0002-s2003-s3004"><title>Cortisol (CORT)</title><p>Procedures for sampling and analyzing cortisol were the same as reported in Bohle et al.<xref rid="cit0052" ref-type="bibr">52</xref> In short, all sampling was performed over two consecutive days, 4 times a day for each timepoint (T1-4). Samples were gathered using a saliva collection device (Sarstedt N&#252;mbrecht, Germany) that consisted of a cotton swab and a sampling vessel. The samples were analyzed by Department of Medical Biochemistry, M&#248;re, and Romsdal Hospital Trust. Cortisol levels were measured using an immunochemical assay on a Roche Cobas 8000 e801 automated analyzer&#160;(Roche Diagnostics, Oslo, Norway). To examine different aspects of HPA axis functioning, the daytime cortisol slope (DCS) and AUC were calculated. DCSs were quantified by calculating the difference between morning and afternoon samples divided by the total time between the two samples.<xref rid="cit0078" ref-type="bibr">78</xref> The area under the curve with respect to the ground (AUC<sub>G</sub>) was calculated according to the method described by Pruessner et al.<xref rid="cit0079" ref-type="bibr">79</xref> The AUC<sub>G</sub> is the total AUC of all measurements for each time point based on the mean time of day for each sample time (ST). The formula for AUC<sub>G</sub> is summarized as: <inline-formula id="ilm0001"><alternatives><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="SAR-14-61-e0001.jpg"/><tex-math id="Tex001">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$AU{C_G} = {\ }\sum i{\ } = {\ }1n - 1\left({{m_{(i +1)}} + {m_i}} \right) \cdot {t_i}2$\end{document}</tex-math></alternatives></inline-formula>, where t<sub>i</sub> denotes the individual time distance between measurements, m<sub>i</sub> denotes the individual measurement, and n represents the total number of measures. In line with recommendations before calculating cortisol, concentrations exceeding 2.5 SD from the mean of each sample time (ST) were excluded from the dataset before calculating the AUC<sub>G</sub> and DCS.<xref rid="cit0080" ref-type="bibr">80&#8211;82</xref></p></sec><sec id="s0002-s2003-s3005"><title>The Ward Atmosphere Scale</title><p>The short form consists of 40 items that assess a variety of features of the therapeutic environment, including relationships, involvement, support, personal growth, autonomy, personal problems, anger and aggression, system maintenance, order, and program clarity.<xref rid="cit0066" ref-type="bibr">66</xref> The respondent is presented with statements such as &#8220;The doctors have little time to cheer up the patients&#8221; and &#8220;The personnel knows what the patients need&#8221; and responds from &#8220;3 &#8211; Strongly agree&#8221; to &#8220;0 &#8211; Strongly disagree&#8221;. Internal consistency of the scale was 0.69, 0.71, and 0.72 (Cronbach&#8217;s alpha) for timepoints 2 to 4.</p></sec><sec id="s0002-s2003-s3006"><title>Motivation</title><p>A modified version of the validated motivation scale of the Circumstances, Motivation, Readiness, and Suitability questionnaire<xref rid="cit0083" ref-type="bibr">83</xref> (CMRS) was used to measure motivation. The CMRS is designed to measure intrinsic motivation and readiness for treatment and predict retention in treatment among abusers of illicit drugs. This scale presents statements such as &#8220;Often I don&#8217;t like myself because of my drug use&#8221; and &#8220;I came to this program because I really feel that I`m ready to deal with myself in treatment&#8221;. The participants are asked to rate these statements from &#8220;1 &#8211;Disagree&#8221; to &#8220;4 &#8211; Strongly Agree&#8221;. Internal consistency of the motivation scale for each timepoint 1&#8211;4 was 0.81, 0.79, 0.82, and 0.86 (Cronbach&#8217;s alpha).</p></sec><sec id="s0002-s2003-s3007"><title>Psychological Distress</title><p>Hopkins Symptom Checklist-10 (SCL-10)<xref rid="cit0084" ref-type="bibr">84</xref> was used as a measure of psychological distress. This study adopted a Norwegian version<xref rid="cit0085" ref-type="bibr">85</xref> of the structured self-administered questionnaire, which includes ten items (suddenly scared for no reason, feeling fearful, faintness, dizziness and weakness (one item and three score options), feeling tense, blaming yourself, difficulties with sleep, feeling of worthlessness, feeling blue, feeling hopeless, and feeling everything is an effort) scored on a 4-point Likert scale from 1 (not at all) to 4 (extremely). Scores were summarized and divided by the number of items, giving a total score between 1 and 4. A mean score of 1.85 is considered a valid cut-off to indicate severe psychological distress.<xref rid="cit0086" ref-type="bibr">86</xref> The internal consistencies of the SCL-10 were between 0.84 and 0.89 (Cronbach&#8217;s alpha) for timepoints 1 to 4.</p></sec></sec><sec id="s0002-s2004"><title>Statistical Analysis</title><p>STATA/SE 16.1 was used for the statistical analyses aimed at the research questions. Univariate analyses and descriptive statistics were performed with IBM SPSS Statistics 27. Statistical significance was set at p &lt; 0.05. Descriptive statistics for continuous variables are presented with means and SDs. Frequency distributions are presented for categorical variables.</p><p>Potential multicollinearity was inspected with variation inflation factor (VIF). VIF-scores were between 1.048 and 2.847, indicating no issues with multicollinearity. Cook&#8217;s distance was used to check for influential cases, and no outliers were detected (criterion set to 1.00).</p><p>Univariate analysis was run to test differences in dropout rates between the two institutions, differences in motivation between the SUD diagnoses, and differences between patients with high HSCL-10 scores (above 1.85). Differences in motivation and the AUC<sub>G</sub> for patients admitted to previous inpatient treatment versus patients with few inpatient stays was also tested (&gt; 2 previous inpatient stays: yes/no).</p><p>In the final analysis, intermediate and multiple logistic regression was used with dropout as the outcome. Variables included in the final model were a combination of main interest (AUC<sub>G</sub>, DCS, SCL-10, WAS, and MOT) and common interest (time, sex, age, institution, SUD diagnosis). Non-significant variables of no particular interest were excluded from the analysis. The final logistic regression model analysis consists of an adjusted logistic regression effect for dropout relative to the change in AUC<sub>G</sub>, DCS, Motivation, Ward Atmosphere (WAS), psychological distress (SCL-10), time, sex, institution, and SUD diagnosis. An interaction between SUD diagnosis and cortisol DCS was included in the final model. Models with only the main effects and models with adjustments for the interaction terms were compared. Models with only main effects were tested before the interaction terms were entered into the model. Only the significant interaction terms were included in the final model (<italic toggle="yes">p</italic>&lt;0.05).</p></sec></sec><sec id="s0003"><title>Results</title><sec id="s0003-s2001"><title>Characteristics of the Study Sample</title><p>Out of the 196 patients who agreed to participate in the study, 173 were included in the final analysis. Seven participants dropped out of treatment after consent was given and before T1. These patients left the clinic and did not return, and thus no research data were collected from this group. Four others withdrew from the study during the data collection period, and 23 patients were excluded from the data set due to extreme values (2.5 SDs above the mean for each sample time: ST).</p><p>The final sample consisted of 129 (74.6%) male and 44 (25.4%) female patients. Age varied from 20 to 69 years, with a mean of 38.94 years (SD = 11.06). The most common SUD diagnosis was alcohol dependence (44.5%, n = 77), and only 5 (2.9%) respondents had the SUD diagnosis of multiple drug use.</p></sec><sec id="s0003-s2002"><title>Univariate Tests</title><p>The univariate analysis revealed a significantly higher age for patients who had been admitted to several (&gt;2) inpatient treatments (<italic toggle="yes">p</italic> = 0.024). At T1, patients admitted to previous inpatient treatment more than 2 times displayed a significantly higher motivation (<italic toggle="yes">p</italic> = 0.002) and a lower AUC<sub>G</sub> (<italic toggle="yes">p</italic> = 0.020). A significantly higher motivation at T1 (but not T2-4) was also found in individuals with alcohol dependence vs dependence on illicit drugs (<italic toggle="yes">p</italic> = 0.002) and patients with a HSCL-10 score above the cut-off at 1.85 (<italic toggle="yes">p</italic> = 0.023).</p><p>In addition, a chi-square test was run to test for differences in dropout rate between the two institutions, correcting for treatment length. Comparing the dropout rates at week 8 in treatment revealed no significant difference between the two institutions (<italic toggle="yes">p</italic> = 0.081).</p></sec><sec id="s0003-s2003"><title>Dropout and Biopsychosocial Variables</title><p>A total of 43 (24.8%) participants dropped out of treatment during this study. Eight patients dropped out after T1 (2 weeks in treatment). Twelve dropped out after both T2 and T3, and 11 patients dropped out after T4. The long-term institution had the highest dropout rate, and males dropped out more often than females. <xref rid="t0001" ref-type="table">Table 1</xref> presents a descriptive comparison of dropouts and treatment completers as well as descriptions for each institution.<table-wrap position="float" id="t0001" orientation="portrait"><label>Table 1</label><caption><p>Sample Characteristics and a Descriptive Comparison of the Two Institutions</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"/><th rowspan="1" colspan="1">Whole Sample</th><th colspan="2" rowspan="1">Institution</th><th colspan="2" rowspan="1">Dropout</th></tr><tr><th rowspan="1" colspan="1">Total</th><th rowspan="1" colspan="1">Short-Term</th><th rowspan="1" colspan="1">Long-Term</th><th rowspan="1" colspan="1">Yes</th><th rowspan="1" colspan="1">No</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Number of subjects, n (%)</td><td rowspan="1" colspan="1">173</td><td rowspan="1" colspan="1">138 (79.8)</td><td rowspan="1" colspan="1">35 (20.2)</td><td rowspan="1" colspan="1">43 (24.8)</td><td rowspan="1" colspan="1">130 (75.14)</td></tr><tr><td rowspan="1" colspan="1">Dropouts, n (%)</td><td rowspan="1" colspan="1">43 (24.8)</td><td rowspan="1" colspan="1">29 (21)</td><td rowspan="1" colspan="1">14 (40)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Sex</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Male, n (%)</td><td rowspan="1" colspan="1">129 (74.5)</td><td rowspan="1" colspan="1">101 (73.2)</td><td rowspan="1" colspan="1">28 (80)</td><td rowspan="1" colspan="1">36 (83.7)</td><td rowspan="1" colspan="1">93 (71.5)</td></tr><tr><td rowspan="1" colspan="1">Female, n (%)</td><td rowspan="1" colspan="1">44 (25.4)</td><td rowspan="1" colspan="1">37 (26.8)</td><td rowspan="1" colspan="1">7 (20)</td><td rowspan="1" colspan="1">7 (16.3)</td><td rowspan="1" colspan="1">33 (26.8)</td></tr><tr><td rowspan="1" colspan="1">SUD diagnosis n (%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Alcohol</td><td rowspan="1" colspan="1">77 (44,5)</td><td rowspan="1" colspan="1">68 (49.3)</td><td rowspan="1" colspan="1">9 (25.7)</td><td rowspan="1" colspan="1">20 (46.5)</td><td rowspan="1" colspan="1">57 (43.8)</td></tr><tr><td rowspan="1" colspan="1">Opioids</td><td rowspan="1" colspan="1">18 (10.4)</td><td rowspan="1" colspan="1">11 (8)</td><td rowspan="1" colspan="1">7 (20)</td><td rowspan="1" colspan="1">5 (11.6)</td><td rowspan="1" colspan="1">13 (10)</td></tr><tr><td rowspan="1" colspan="1">Stimulants</td><td rowspan="1" colspan="1">38 (22)</td><td rowspan="1" colspan="1">29 (21)</td><td rowspan="1" colspan="1">9 (25.7)</td><td rowspan="1" colspan="1">11 (25.6)</td><td rowspan="1" colspan="1">27 (20.8)</td></tr><tr><td rowspan="1" colspan="1">Cannabinoids</td><td rowspan="1" colspan="1">24 (13.9)</td><td rowspan="1" colspan="1">17 (12.3)</td><td rowspan="1" colspan="1">7 (20)</td><td rowspan="1" colspan="1">5 (11.6)</td><td rowspan="1" colspan="1">19 (14.6)</td></tr><tr><td rowspan="1" colspan="1">Sedative hypnotics</td><td rowspan="1" colspan="1">8 (4.6)</td><td rowspan="1" colspan="1">7 (5.1)</td><td rowspan="1" colspan="1">1 (2.9)</td><td rowspan="1" colspan="1">1 (2.2)</td><td rowspan="1" colspan="1">7 (5.4)</td></tr><tr><td rowspan="1" colspan="1">Multiple drug use</td><td rowspan="1" colspan="1">5 (2.9)</td><td rowspan="1" colspan="1">3 (2.2)</td><td rowspan="1" colspan="1">2 (5.7)</td><td rowspan="1" colspan="1">1 (2.2)</td><td rowspan="1" colspan="1">4 (3.1)</td></tr></tbody></table></table-wrap></p><p>A total of 4405 salivary cortisol samples were collected and analyzed in this study. Mean values for each sample time (ST) across the timepoints (T1&#8211;T4) were 6.74 nmol/l at ST1 (SD = 3.09, Range: 1.5&#8211;21.6), 6.59 nmol/l at ST2 (SD = 3.00, Range: 1.5&#8211;16.9), 6.52 nmol/l at ST3 (SD = 2.95, Range: 1.5&#8211;16.2), and 6.48 nmol/l at ST4 (SD = 2.91, Range 1.5&#8211;23.7). The mean and standard deviation for the cortisol indexes (AUC<sub>G</sub> and DCS) for each time point are presented in <xref rid="t0002" ref-type="table">Table 2</xref>, which also shows whether or not patients dropped out.<table-wrap position="float" id="t0002" orientation="portrait"><label>Table 2</label><caption><p>Overview of the Development of the Biopsychosocial Variables (AUC<sub>G</sub>, DCS, HSCL-10, WAS and MOT) at Each Timepoint Divided into Dropout Yes/No</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"/><th rowspan="2" colspan="1">Dropout</th><th align="center" colspan="2" rowspan="1">T1<sup>a</sup></th><th align="center" colspan="2" rowspan="1">T2<sup>b</sup></th><th align="center" colspan="2" rowspan="1">T3<sup>c</sup></th><th align="center" colspan="2" rowspan="1">T4<sup>d</sup></th></tr><tr><th rowspan="1" colspan="1">Mean</th><th rowspan="1" colspan="1">SD</th><th rowspan="1" colspan="1">Mean</th><th rowspan="1" colspan="1">SD</th><th rowspan="1" colspan="1">Mean</th><th rowspan="1" colspan="1">SD</th><th rowspan="1" colspan="1">Mean</th><th rowspan="1" colspan="1">SD</th></tr></thead><tbody><tr><td rowspan="2" colspan="1">AUC<sub>G</sub></td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">40</td><td rowspan="1" colspan="1">21.1</td><td rowspan="1" colspan="1">30.99</td><td rowspan="1" colspan="1">14.84</td><td rowspan="1" colspan="1">30.08</td><td rowspan="1" colspan="1">10.06</td><td rowspan="1" colspan="1">33.06</td><td rowspan="1" colspan="1">26.99</td></tr><tr><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">46.09</td><td rowspan="1" colspan="1">22.55</td><td rowspan="1" colspan="1">39.76</td><td rowspan="1" colspan="1">16.36</td><td rowspan="1" colspan="1">37.42</td><td rowspan="1" colspan="1">14.72</td><td rowspan="1" colspan="1">40.01</td><td rowspan="1" colspan="1">21.31</td></tr><tr><td rowspan="2" colspan="1">DCS</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">1.04</td><td rowspan="1" colspan="1">0.75</td><td rowspan="1" colspan="1">0.99</td><td rowspan="1" colspan="1">0.81</td><td rowspan="1" colspan="1">1.03</td><td rowspan="1" colspan="1">0.64</td><td rowspan="1" colspan="1">1.23</td><td rowspan="1" colspan="1">0.8</td></tr><tr><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">1.28</td><td rowspan="1" colspan="1">0.94</td><td rowspan="1" colspan="1">1.19</td><td rowspan="1" colspan="1">0.79</td><td rowspan="1" colspan="1">1.28</td><td rowspan="1" colspan="1">0.86</td><td rowspan="1" colspan="1">1.08</td><td rowspan="1" colspan="1">0.75</td></tr><tr><td rowspan="2" colspan="1">HSCL-10</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">2.25</td><td rowspan="1" colspan="1">0.79</td><td rowspan="1" colspan="1">2.09</td><td rowspan="1" colspan="1">0.68</td><td rowspan="1" colspan="1">1.95</td><td rowspan="1" colspan="1">1.01</td><td rowspan="1" colspan="1">2.22</td><td rowspan="1" colspan="1">0.70</td></tr><tr><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">2.29</td><td rowspan="1" colspan="1">0.69</td><td rowspan="1" colspan="1">2.06</td><td rowspan="1" colspan="1">0.64</td><td rowspan="1" colspan="1">2.04</td><td rowspan="1" colspan="1">0.70</td><td rowspan="1" colspan="1">1.89</td><td rowspan="1" colspan="1">0.68</td></tr><tr><td rowspan="2" colspan="1">MOT</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">17.02</td><td rowspan="1" colspan="1">3.06</td><td rowspan="1" colspan="1">16.73</td><td rowspan="1" colspan="1">3.30</td><td rowspan="1" colspan="1">17.27</td><td rowspan="1" colspan="1">2.34</td><td rowspan="1" colspan="1">18.22</td><td rowspan="1" colspan="1">1.78</td></tr><tr><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">17.42</td><td rowspan="1" colspan="1">3.19</td><td rowspan="1" colspan="1">16.99</td><td rowspan="1" colspan="1">3.12</td><td rowspan="1" colspan="1">17.15</td><td rowspan="1" colspan="1">3.32</td><td rowspan="1" colspan="1">16.64</td><td rowspan="1" colspan="1">3.72</td></tr><tr><td rowspan="2" colspan="1">WAS</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">23.96</td><td rowspan="1" colspan="1">6.00</td><td rowspan="1" colspan="1">25.00</td><td rowspan="1" colspan="1">6.36</td><td rowspan="1" colspan="1">28.00</td><td rowspan="1" colspan="1">6.86</td></tr><tr><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">25.51</td><td rowspan="1" colspan="1">4.57</td><td rowspan="1" colspan="1">25.84</td><td rowspan="1" colspan="1">5.33</td><td rowspan="1" colspan="1">25.38</td><td rowspan="1" colspan="1">5.37</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><bold>Notes</bold>: <sup>a</sup>T1: Time point 1 during the second treatment week; <sup>b</sup>T2 is in week 4; <sup>c</sup>T3 is in week 6; and <sup>d</sup>T4 is in week 8.</p></fn><fn id="tfn0002"><p><bold>Abbreviations</bold>: SD, standard deviation; AUG<sub>G</sub>, Area under the curve with respect to ground; DCS, Diurnal cortisol slope; HSCL-10, Hopkins symptom checklist 10; MOT, Motivation; WAS, Ward Atmosphere scale were not included at the first timepoint.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="s0003-s2004"><title>Main Results</title><p>For the unadjusted analysis, the effect of one variable at a time on dropout was assessed (<xref rid="t0003" ref-type="table">Table 3</xref>). The only significant variable in the unadjusted analysis was institution. Patients were 64% less likely to drop out from the short-term treatment program. Sex differences were also close to significance, with a 56% lower odds of dropout among women. Psychiatric diagnoses, years of addiction, and number of times in treatment were not significantly associated with dropout and were therefore excluded from further analysis. However, the other non-significant variables were included in further analysis due to the fact that they were main explanatory variables or of general interest to our study.<table-wrap position="float" id="t0003" orientation="portrait"><label>Table 3</label><caption><p>Association Between AUC<sub>G</sub> or DCS and Dropout Adjusted for Time, Age, Sex, Institution, Number of Psychiatric Diagnoses, Years of Addiction, and SUD Diagnosis. Unadjusted and Adjusted Multiple Regression Analyses</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"/><th align="center" colspan="2" rowspan="1">Unadjusted Effects</th><th rowspan="2" align="center" colspan="1">P values</th><th align="center" colspan="2" rowspan="1">Adjusted Effects &#8211; Model with Main Effects</th><th rowspan="2" align="center" colspan="1">P values</th><th align="center" colspan="2" rowspan="1">Adjusted Effects &#8211; Model with Main Effects and Interactions</th><th rowspan="2" align="center" colspan="1">P values</th></tr><tr><th rowspan="1" colspan="1">OR</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1">OR</th><th rowspan="1" colspan="1">95% CI</th><th rowspan="1" colspan="1">OR</th><th rowspan="1" colspan="1">95% CI</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">AUC<sub>G</sub></td><td rowspan="1" colspan="1">0.98</td><td rowspan="1" colspan="1">0.96: 1.00</td><td rowspan="1" colspan="1">0.178</td><td rowspan="1" colspan="1">0.97</td><td rowspan="1" colspan="1">0.94: 1.01</td><td rowspan="1" colspan="1">0.132</td><td rowspan="1" colspan="1">0.97</td><td rowspan="1" colspan="1">0.92: 1.02</td><td rowspan="1" colspan="1">0.277</td></tr><tr><td rowspan="1" colspan="1">DCS</td><td rowspan="1" colspan="1">0.87</td><td rowspan="1" colspan="1">0.58: 1.31</td><td rowspan="1" colspan="1">0.525</td><td rowspan="1" colspan="1">1.19</td><td rowspan="1" colspan="1">0.48: 2.93</td><td rowspan="1" colspan="1">0.679</td><td rowspan="1" colspan="1">0.28</td><td rowspan="1" colspan="1">0.06: 1.31</td><td rowspan="1" colspan="1">0.107</td></tr><tr><td rowspan="1" colspan="1"><bold>Motivation</bold></td><td rowspan="1" colspan="1">0.99</td><td rowspan="1" colspan="1">0.89: 1.10</td><td rowspan="1" colspan="1">0.890</td><td rowspan="1" colspan="1"><bold>0.82</bold></td><td rowspan="1" colspan="1"><bold>0.67: 0.99</bold></td><td rowspan="1" colspan="1"><bold>0.049</bold></td><td rowspan="1" colspan="1"><bold>0.76</bold></td><td rowspan="1" colspan="1"><bold>0.60: 0.96</bold></td><td rowspan="1" colspan="1"><bold>0.022</bold></td></tr><tr><td rowspan="1" colspan="1">Ward Atmosphere</td><td rowspan="1" colspan="1">0.96</td><td rowspan="1" colspan="1">0.89: 1.04</td><td rowspan="1" colspan="1">0.368</td><td rowspan="1" colspan="1">0.99</td><td rowspan="1" colspan="1">0.87: 1.12</td><td rowspan="1" colspan="1">0.903</td><td rowspan="1" colspan="1">0.98</td><td rowspan="1" colspan="1">0.85: 1.12</td><td rowspan="1" colspan="1">0.781</td></tr><tr><td rowspan="1" colspan="1">Psychological distress</td><td rowspan="1" colspan="1">0.98</td><td rowspan="1" colspan="1">0.94: 1.03</td><td rowspan="1" colspan="1">0.601</td><td rowspan="1" colspan="1">1.077</td><td rowspan="1" colspan="1">0.96: 1.19</td><td rowspan="1" colspan="1">0.171</td><td rowspan="1" colspan="1">1.09</td><td rowspan="1" colspan="1">0.97: 1.23</td><td rowspan="1" colspan="1">0.128</td></tr><tr><td rowspan="1" colspan="1">HSCL-10 Cutoff</td><td rowspan="1" colspan="1">0.67</td><td rowspan="1" colspan="1">0.34: 1.32</td><td rowspan="1" colspan="1">0.258</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">Time</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.864</td></tr><tr><td rowspan="1" colspan="1">T1</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">T2</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.85</td><td rowspan="1" colspan="1">0.17: 4.06</td><td rowspan="1" colspan="1">0.843</td><td rowspan="1" colspan="1">0.67</td><td rowspan="1" colspan="1">0.12: 3.70</td><td rowspan="1" colspan="1">0.655</td></tr><tr><td rowspan="1" colspan="1">T3</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">0.78</td><td rowspan="1" colspan="1">0.15: 4.03</td><td rowspan="1" colspan="1">0.771</td><td rowspan="1" colspan="1">0.63</td><td rowspan="1" colspan="1">0.11: 3.59</td><td rowspan="1" colspan="1">0.608</td></tr><tr><td rowspan="1" colspan="1">T4</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">(Omitted)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">(Omitted)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Age</td><td rowspan="1" colspan="1">0.99</td><td rowspan="1" colspan="1">0.96: 1.02</td><td rowspan="1" colspan="1">0.862</td><td rowspan="1" colspan="1">1.05</td><td rowspan="1" colspan="1">0.97: 1.14</td><td rowspan="1" colspan="1">0.158</td><td rowspan="1" colspan="1">1.05</td><td rowspan="1" colspan="1">0.97: 1.15</td><td rowspan="1" colspan="1">0.191</td></tr><tr><td rowspan="1" colspan="1">Sex</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">0.44</td><td rowspan="1" colspan="1">0.18: 1.07</td><td rowspan="1" colspan="1">0.072</td><td rowspan="1" colspan="1">0.43</td><td rowspan="1" colspan="1">0.07: 2.41</td><td rowspan="1" colspan="1">0.341</td><td rowspan="1" colspan="1">0.33</td><td rowspan="1" colspan="1">0.05: 2.15</td><td rowspan="1" colspan="1">0.250</td></tr><tr><td rowspan="1" colspan="1">Institution</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Long&#8211;term</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><bold>Short&#8211;term</bold></td><td rowspan="1" colspan="1"><bold>0.36</bold></td><td rowspan="1" colspan="1"><bold>0.19: 0.69</bold></td><td rowspan="1" colspan="1"><bold>0.002</bold></td><td rowspan="1" colspan="1"><bold>0.13</bold></td><td rowspan="1" colspan="1"><bold>0.02: 0.65</bold></td><td rowspan="1" colspan="1"><bold>0.013</bold></td><td rowspan="1" colspan="1"><bold>0.06</bold></td><td rowspan="1" colspan="1"><bold>0.01: 0.44</bold></td><td rowspan="1" colspan="1"><bold>0.005</bold></td></tr><tr><td rowspan="1" colspan="1">Psychiatric diagnoses</td><td rowspan="1" colspan="1">0.99</td><td rowspan="1" colspan="1">0.77: 1.28</td><td rowspan="1" colspan="1">0.987</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">Years of addiction</td><td rowspan="1" colspan="1">1.02</td><td rowspan="1" colspan="1">0.99: 1.05</td><td rowspan="1" colspan="1">0.095</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">Number of treatments</td><td rowspan="1" colspan="1">1.09</td><td rowspan="1" colspan="1">0.86: 1.39</td><td rowspan="1" colspan="1">0.451</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td></tr><tr><td rowspan="1" colspan="1">SUD diagnosis</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Alcohol</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1">&#8211;</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Opioids</td><td rowspan="1" colspan="1">1.46</td><td rowspan="1" colspan="1">0.55: 3.84</td><td rowspan="1" colspan="1">0.439</td><td rowspan="1" colspan="1">1.13</td><td rowspan="1" colspan="1">0.11: 10.87</td><td rowspan="1" colspan="1">0.914</td><td rowspan="1" colspan="1">0.17</td><td rowspan="1" colspan="1">0.00: 4.65</td><td rowspan="1" colspan="1">0.296</td></tr><tr><td rowspan="1" colspan="1">Stimulants</td><td rowspan="1" colspan="1">1.14</td><td rowspan="1" colspan="1">0.51: 2.53</td><td rowspan="1" colspan="1">0.743</td><td rowspan="1" colspan="1">0.59</td><td rowspan="1" colspan="1">0.24: 10.27</td><td rowspan="1" colspan="1">0.621</td><td rowspan="1" colspan="1">0.09</td><td rowspan="1" colspan="1">0.00: 2.44</td><td rowspan="1" colspan="1">0.155</td></tr><tr><td rowspan="1" colspan="1">Cannabinoids</td><td rowspan="1" colspan="1">0.43</td><td rowspan="1" colspan="1">0.12: 1.51</td><td rowspan="1" colspan="1">0.192</td><td rowspan="1" colspan="1">0.50</td><td rowspan="1" colspan="1">0.04: 6.10</td><td rowspan="1" colspan="1">0.589</td><td rowspan="1" colspan="1">0.01</td><td rowspan="1" colspan="1">0.00: 8.21</td><td rowspan="1" colspan="1">0.202</td></tr><tr><td rowspan="1" colspan="1">Sedative Hypnotics</td><td rowspan="1" colspan="1">0.42</td><td rowspan="1" colspan="1">0.05: 3.27</td><td rowspan="1" colspan="1">0.410</td><td rowspan="1" colspan="1">1.34</td><td rowspan="1" colspan="1">0.11: 15.51</td><td rowspan="1" colspan="1">0.810</td><td rowspan="1" colspan="1">0.10</td><td rowspan="1" colspan="1">0.00: 22.99</td><td rowspan="1" colspan="1">0.412</td></tr><tr><td rowspan="1" colspan="1">Multiple drug use</td><td rowspan="1" colspan="1">1.95</td><td rowspan="1" colspan="1">0.40: 9.28</td><td rowspan="1" colspan="1">0.401</td><td rowspan="1" colspan="1">3.66</td><td rowspan="1" colspan="1">0.20: 66.38</td><td rowspan="1" colspan="1">0.380</td><td rowspan="1" colspan="1">0.16</td><td rowspan="1" colspan="1">0.00: 1501.7</td><td rowspan="1" colspan="1">0.702</td></tr></tbody></table><table-wrap-foot><fn id="tfn0003"><p><bold>Note</bold>: Significant findings are highlighted in bold.</p></fn><fn id="tfn0004"><p><bold>Abbreviations</bold>: OR, Odds Ratio; CI, Confidence interval; AUC<sub>G</sub>, Area under the curve with respect to ground; DCS, Diurnal cortisol slope; HSCL&#8211;10, Hopkins symptom checklist &#8722;10; T1&#8211;T4, Timepoint 1 to 4.</p></fn></table-wrap-foot></table-wrap></p><p>The adjusted analysis tested the effect of the explanatory variables (AUC<sub>G</sub>, DCS, motivation, WAS, and psychological distress) on dropout, adjusting for time, age, sex, institution, and SUD diagnosis. This analysis showed a significant association between motivation and drop-out, where every one unit-increase (the scale ranging from 5 to 20) in motivation decreased dropout risk by 1%.</p><p>The results also demonstrated a significant effect for a contextual variable: type of institution. Being admitted to short-term treatment reduced the risk of dropping out by 87%, adjusting for the other variables in the model.</p><p>In the final multivariate logistic regression analysis (<xref rid="t0003" ref-type="table">Table 3</xref>), we analyzed the association between the explanatory variables (AUC<sub>G</sub>, DCS, motivation, WAS, and psychological distress) and dropout, which was adjusted for time, sex, age, institution, and SUD diagnosis. The interaction between SUD diagnosis and DCS was also included in this model (<xref rid="t0004" ref-type="table">Table 4</xref>). The analysis revealed a significant main effect between motivation, institution, and dropout. The main effect for motivation demonstrated that the odds of dropout decreased by 24% for each unit increase in motivation. With respect to the type of institution, being admitted to short-term treatment decreased the dropout odds by 87% when adjusted for the other variables in the model. The interaction between DCS and SUD diagnosis as a whole was not significant, but there was a significant difference between individuals suffering from alcohol dependence versus stimulants. The results showed an increased odds of dropout by 13.74 times for individuals with dependence of stimulants compared to alcohol, dependent on the DCS.<table-wrap position="float" id="t0004" orientation="portrait"><label>Table 4</label><caption><p>Extension of <xref rid="t0003" ref-type="table">Table 3</xref> Results for the Interaction Between SUD Diagnosis and Cortisol DCS</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Interaction</th><th rowspan="1" colspan="1">&#160;OR</th><th rowspan="1" colspan="1">&#160;95% CI</th><th rowspan="1" colspan="1">P values</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">SUD diagnosis # DCS</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.754</td></tr><tr><td rowspan="1" colspan="1">Alcohol</td><td rowspan="1" colspan="1">1.00</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Opioids</td><td rowspan="1" colspan="1">5.97</td><td rowspan="1" colspan="1">0.43: 82.54</td><td rowspan="1" colspan="1">0.181</td></tr><tr><td rowspan="1" colspan="1"><bold>Stimulants</bold></td><td rowspan="1" colspan="1"><bold>13.74</bold></td><td rowspan="1" colspan="1"><bold>1.40: 134.64</bold></td><td rowspan="1" colspan="1"><bold>0.024</bold></td></tr><tr><td rowspan="1" colspan="1">Cannabinoids</td><td rowspan="1" colspan="1">14.81</td><td rowspan="1" colspan="1">0.37: 593.22</td><td rowspan="1" colspan="1">0.152</td></tr><tr><td rowspan="1" colspan="1">Sedative hypnotics</td><td rowspan="1" colspan="1">8.95</td><td rowspan="1" colspan="1">0.40: 198.23</td><td rowspan="1" colspan="1">0.165</td></tr><tr><td rowspan="1" colspan="1">Multiple drug use</td><td rowspan="1" colspan="1">12.33</td><td rowspan="1" colspan="1">0.01: 29,527.51</td><td rowspan="1" colspan="1">0.439</td></tr></tbody></table><table-wrap-foot><fn id="tfn0005"><p><bold>Note</bold>: Significant findings highlighted in bold.</p></fn><fn id="tfn0006"><p><bold>Abbreviations</bold>: OR, Odds Ratio; CI, Confidence interval.</p></fn></table-wrap-foot></table-wrap></p></sec></sec><sec id="s0004"><title>Discussion</title><p>In this prospective naturalistic study, the association between biopsychosocial measures and dropout was investigated. According to the biopsychosocial model of addiction, several dimensions, from the molecular to the social level, affect SUD.<xref rid="cit0025" ref-type="bibr">25</xref>,<xref rid="cit0026" ref-type="bibr">26</xref> Findings from a multiple logistic regression analysis revealed a significant association between motivation and dropout, but not for the other biopsychosocial variables (HSCL-10, CORT, and WAS). In the final logistic regression model, higher motivation was found to lower dropout odds by 24% per one-unit increase in motivation.</p><p>Motivation had a significant (<italic toggle="yes">p</italic> &lt; 0.05) association with dropout in both the adjusted, and the final logistic regression model. The minimum score on the motivation scale is 5, representing low treatment motivation, and highest possible score is 20. <xref rid="t0002" ref-type="table">Table 2</xref>, which presents the development of the explanatory variables through all timepoints, reveals that the mean motivation score is quite high for both groups at the first timepoint, above 17 for both dropouts and treatment completers. This is consistent with previous findings, where pre-treatment motivation has been found to predict dropout from substance addiction treatment.<xref rid="cit0074" ref-type="bibr">74&#8211;76</xref> Studies investigating motivational interviewing (MI) as a way to enhance participation and retention in substance addiction treatment have shown dispersed results,<xref rid="cit0086" ref-type="bibr">86&#8211;88</xref> but it has been argued that MI is better than no intervention.<xref rid="cit0089" ref-type="bibr">89</xref> Broome et al<xref rid="cit0090" ref-type="bibr">90</xref> found that an important factor for motivation were support of significant others. Further research on biopsychosocial factors and dropout should therefore include social networks outside the clinic. Haviv and Hasisi,<xref rid="cit0007" ref-type="bibr">7</xref> comparing different prison addiction treatment programs, argue that motivation itself cannot explain decreased recidivism rates. They argue that only an interaction between high motivation and a good treatment program could produce ideal outcomes. In the present study, both treatment length and the Ward atmosphere was controlled for, but future studies could put more emphasis on type of treatment factors as Haviv and Hasisi did.</p><p>The results show an increased risk of dropout by almost 14 times for individuals with stimulant dependence, compared to dependence of alcohol, depending on the DCS. This indicates a lower DCS (ie, a flatter curve) in patients with alcohol dependence than in patients with stimulant dependency. Previous findings comparing people with SUD with healthy controls testify to a flattened cortisol curve in patients with alcohol dependency,<xref rid="cit0048" ref-type="bibr">48</xref>,<xref rid="cit0061" ref-type="bibr">61</xref> but this does not seem to heighten the dropout risk in our sample. In our sample, the steeper curve in patients with stimulant addiction is associated with dropping out of treatment. As there are few studies investigating basal cortisol levels in stimulant dependent individuals, these findings are difficult to interpret. However, the effect of cocaine on the HPA-axis has been well-demonstrated, and individuals with cocaine dependence have been shown to display higher levels of cortisol when the drug is administered.<xref rid="cit0091" ref-type="bibr">91</xref> Elevated levels of basal cortisol have been found in non-abstinent cocaine dependent individuals,<xref rid="cit0092" ref-type="bibr">92</xref> and increased morning levels of cortisol have been found to be associated with retention in crack cocaine users.<xref rid="cit0009" ref-type="bibr">9</xref> The effect of amphetamines on the HPA-axis and cortisol levels seems to be more complicated, and more research is needed.<xref rid="cit0093" ref-type="bibr">93</xref> The DCS represents the curve from morning to afternoon in our sample, where a higher DCS value represents a larger decline in cortisol during the day. The higher the morning values, the higher the DCS value. This association could therefore be comparable to the elevated morning cortisol in individuals with cocaine addiction<xref rid="cit0009" ref-type="bibr">9</xref> even if the study protocol is not similar. Chronic stimulant use is known to increase stress reactivity in abstinent rats and humans,<xref rid="cit0094" ref-type="bibr">94</xref> and the steeper DCS in patients addicted to stimulants might thus influence the risk of stress-induced relapse. The results for stimulant dependent individuals in our sample could be in line with previous studies suggesting a dysregulation of the HPA axis in individuals with SUD.<xref rid="cit0009" ref-type="bibr">9</xref>,<xref rid="cit0095" ref-type="bibr">95</xref>,<xref rid="cit0096" ref-type="bibr">96</xref></p><p>Looking at the univariate statistics reveals that patients going through treatment for the 3rd or 4th time both have a higher motivation and a lower AUC<sub>G</sub>. A higher level of motivation is also found in individuals with severe psychological distress and those with a SUD of alcohol dependence. The significant association between age and several treatments could also have a connection with the severity of substance use history or how many years they have been using substances. The group of patients with several previous inpatient stays also have a significantly lower AUC<sub>G</sub>, which is interesting. As previously mentioned, the results for basal cortisol levels in individuals with SUD have been inconsistent, but one could maybe theorize that a more severe substance use history could have a more severe effect on the HPA-axis and hence the cortisol levels.</p><p>Several reasons could exist that explain the higher level of motivation in individuals who were admitted to treatment before. It might be that previous inpatient stays and the experience with the demands that it entails could help individuals feel more prepared. The significant association between severe psychological distress and motivation is also interesting because psychological distress did not have a significant effect on dropout. In the case of high motivation in individuals with a score above 1.85 on the HSCL-10, high psychological burden could be a source of motivation. Patients suffering from a high symptom load of psychological distress might be motivated to get treatment in order to find some sort of symptom relief, but it could also be that the motivation itself could produce the stress. Andersson et al&#8217;s 2018 study also used both the HSCL-10 and the M-scale from the CMRS.<xref rid="cit0016" ref-type="bibr">16</xref> They found that higher psychological distress and higher motivation predicted dropout. Another study investigated the role of motivation and distress tolerance for retention and found a significant interaction between high motivation and high distress tolerance in predicting retention.<xref rid="cit0040" ref-type="bibr">40</xref> Because there are few studies that investigate the combined role of motivation and psychological distress,<xref rid="cit0016" ref-type="bibr">16</xref> future research may want to address this association and include distress tolerance in their investigations.</p><p>We did not find a significant association between dropout and psychological distress or perceived ward atmosphere (WAS) in this study. The WAS might not have been significant because it could have just not been an important risk factor. Another explanation could be that the sample came from two different institutions with different treatment lengths and structures. <xref rid="t0002" ref-type="table">Table 2</xref> displays the mean scores for WAS for both dropouts and treatment completers for each timepoint. The highest possible WAS score is 40, where the mean for the treatment completers is stable at around 25 across all timepoints. The mean for the dropouts varies between below and over 25, but this is probably due to the fact that the number of participants was not stable over the timepoints since some dropped out. Psychological distress was high and similar for dropouts and treatment completers. This tells us that both groups have severe psychological distress, taking the cut-off at 1.85 into account. This aligns with previous findings for the patient group, both for the SCL-10 and for the general co-occurrence of mental disorders in the SUD population.<xref rid="cit0029" ref-type="bibr">29</xref>,<xref rid="cit0097" ref-type="bibr">97&#8211;99</xref> The non-significance in predicting dropout could be due to properties of the HSCL-10. It could be that the measure is not specific or detailed enough to use in the field of substance addiction. However, previous research has found associations between psychological distress and dropout,<xref rid="cit0016" ref-type="bibr">16</xref> so the explanation could also be related to our specific sample rather than the HSCL-10.</p><p>Furthermore, the number of psychiatric disorders did not predict dropout. The same was the case for years of addiction and number of times in treatment. A possible explanation for this might be that having many co-occurring psychiatric diagnoses and going through treatment for the 3rd or 4th time could possibly make both the individual and their therapist aware of the situation, which might lead them to individualize treatment as necessary.</p><p>The results showed a significant difference between the institutions, where being admitted to long-term treatment gives a higher risk of dropping out of treatment. However, this finding should be interpreted with caution due to the difference in treatment length. To check for this issue, a univariate test comparing the dropout rate in week 8 of treatment revealed no significant difference in dropout rates between short-term and long-term treatment. This could indicate that the higher dropout risk at the long-term clinic is due to longer &#8220;time at risk&#8221;.</p></sec><sec id="s0005"><title>Strengths and Limitations</title><sec id="s0005-s2001"><title>Strengths</title><p>This study has several strengths. First, the prospective design allowed for repeated measures, giving important information about how biopsychosocial factors develops during treatment. Second, the use of both biological and self-reported measures allowed for testing a biopsychosocial model, which is scarce in research on drop-out in substance misuse services. Third, the measuring of cortisol over two consecutive days with 4 samples each day in addition to the use of two different cortisol indices is a strength. These actions were taken to minimize the effect of blunted cortisol activity and random values and provide reliable and valid test samples if a patient missed one or more sample appointments. Fourth, we compared explanatory variables for dropout between short-time and medium-time services.</p></sec><sec id="s0005-s2002"><title>Limitations</title><p>Though this is not necessarily a limitation, we wanted to address the use of a dichotomous outcome variable (dropout: yes/no) and the choice of logistic regression for data analysis. With a continuous variable (days in treatment), a Cox regression survival analysis could be an alternative. However, the exact number of days in treatment was not possible to determine; hence, a logistic regression was the best fit for our data.</p><p>There are several limitations connected to the salivary cortisol sampling protocol. First, we did not control for waking time and thus cannot be sure of avoiding the cortisol awakening response (CAR). Second, the use of caffeine or nicotine prior to sampling was not controlled for in the statistical analysis. Instead, we inspected all samples for unusual values, and samples exceeding 2.5 standard deviations from the mean of each sample time were excluded from the data set and further analysis.</p><p>The number and timing of timepoints could also be a limitation. The first timepoint was performed in the second treatment week, and the following timepoints occurred every other week until the 8th treatment week. Collecting the first measurement earlier, in the first treatment week, could probably give more information and a more reliable baseline. This would also give a higher participation rate since the patients who dropped out before the first measurement could not participate in the study. Collecting the first measurement on the first treatment day could also provide important information about these early dropouts, who we now know little about.</p><p>We did not collect information about cravings in this study. As previous studies have found an association between cravings and retention, this is something we could have monitored. Since psychological distress was not significantly associated with dropout, it would have been interesting to see if there is an association between cravings and dropout, as cravings could produce stress and possibly affect motivation.</p></sec></sec><sec id="s0006"><title>Conclusion</title><p>In conclusion, our results suggest an association between motivation, sex, and treatment length and an interaction between cortisol DCS and stimulant dependency in predicting dropout. There were no significant results for psychological distress or ward atmosphere in predicting dropout. The results could indicate that different HPA reactivity is dependent on the substances used and that being motivated to participate in treatment is important. The univariate analysis also reveals interesting associations between motivation and times in treatment, psychological distress, cortisol levels, and suffering from alcohol dependence. Assessment of motivation and cortisol during treatment could inform clinicians of the need to tailor interventions toward stress regulation and enhancing motivation in order to increase retention. Future studies may want to monitor other possible risk factors of dropping out of treatment, and the use of a stricter sampling protocol for salivary cortisol is also recommended.</p><p>In summary, and as expected, no breakthrough regarding biopsychosocial model for dropout was discovered in this study. Nevertheless, our research represents a small step towards developing this important field of clinical research.</p></sec></body><back><ack><title>Acknowledgments</title><p>We wish to thank all the patients who agreed to participate in this research and the institutions that allowed us to implement the study. Special thanks to the participating institutions and to Marit B&#230;vre Bergseth (HMR) for assisting with the data collection. Petter Laake (UiO) also deserves a special mention for helping with the statistical analyses. Biobank1 at &#197;lesund Hospital helped with the storage of salivary samples during the data collection process. We would also like to acknowledge the Department of Medical Biochemistry, M&#248;re, and Romsdal Hospital Trust for performing the cortisol analyses. We would like to thank Charlesworth Author Services (<underline><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.charlesworthauthorservices.com" ext-link-type="uri">www.charlesworthauthorservices.com</ext-link></underline>) for English language editing.</p></ack><sec id="s0007"><title>Ethics</title><p>The authors have provided the publisher with confirmation that they complied with the legal and ethical obligations. The Regional Committee for Medical Research Ethics in Central Norway approved this study in January 2018 (approval #2017/2057/REK-Midt). We confirm that the study complies with the Declaration of Helsinki.</p></sec><sec id="s0008"><title>Author Contributions</title><p>All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, or analysis and interpretation of data. Further, all authors participated in drafting, revising and critically reviewing the article, and all gave final approval of the version to be published. All authors have agreed on the choice of journal to which the article has been submitted and agree to be held accountable for all aspects of the work.</p></sec><sec sec-type="COI-statement" id="s0009"><title>Disclosure</title><p>All authors declare that they have no conflicts of interest.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>1.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Malivert</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Fats&#233;as</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Denis</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Langlois</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Auriacombe</surname><given-names>M</given-names></string-name>. <article-title>Effectiveness of therapeutic communities: a systematic review</article-title>. <source><italic toggle="yes">Eur Addict Res</italic></source>. <year>2012</year>;<volume>18</volume>(<issue>1</issue>):<fpage>1</fpage>&#8211;<lpage>11</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000331007</pub-id><pub-id pub-id-type="pmid">21997500</pub-id></mixed-citation></ref><ref id="cit0002"><label>2.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Andersson</surname><given-names>HW</given-names></string-name>, <string-name name-style="western"><surname>Wenaas</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Nordfj&#230;rn</surname><given-names>T</given-names></string-name>. <article-title>Relapse after inpatient substance use treatment: a prospective cohort study among users of illicit substances</article-title>. <source><italic toggle="yes">Addict Behav</italic></source>. <year>2019</year>;<volume>90</volume>:<fpage>222</fpage>&#8211;<lpage>228</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.addbeh.2018.11.008</pub-id><pub-id pub-id-type="pmid">30447514</pub-id></mixed-citation></ref><ref id="cit0003"><label>3.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Hubbard</surname><given-names>RL</given-names></string-name>, <string-name name-style="western"><surname>Craddock</surname><given-names>SG</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>J</given-names></string-name>. <article-title>Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS)</article-title>. <source><italic toggle="yes">J Subst Abuse Treat</italic></source>. <year>2003</year>;<volume>25</volume>(<issue>3</issue>):<fpage>125</fpage>&#8211;<lpage>134</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0740-5472(03)00130-2</pub-id><pub-id pub-id-type="pmid">14670518</pub-id></mixed-citation></ref><ref id="cit0004"><label>4.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Magor-Blatch</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Bhullar</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Thomson</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Thorsteinsson</surname><given-names>E</given-names></string-name>. <article-title>A systematic review of studies examining effectiveness of therapeutic communities</article-title>. <source><italic toggle="yes">Ther Communities</italic></source>. <year>2014</year>;<volume>35</volume>(<issue>4</issue>):<fpage>168</fpage>&#8211;<lpage>184</lpage>. doi:<pub-id pub-id-type="doi">10.1108/TC-07-2013-0024/FULL/XML</pub-id></mixed-citation></ref><ref id="cit0005"><label>5.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Magill</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ray</surname><given-names>LA</given-names></string-name>. <article-title>Cognitive-behavioral treatment with adult alcohol ad illicit drug users: a meta-analysis of randomized controlled trials*</article-title>. <source><italic toggle="yes">J Stud Alcohol Drugs</italic></source>. <year>2009</year>;<volume>70</volume>(<issue>4</issue>):<fpage>516</fpage>&#8211;<lpage>527</lpage>. doi:<pub-id pub-id-type="doi">10.15288/jsad.2009.70.516</pub-id><pub-id pub-id-type="pmid">19515291</pub-id><pub-id pub-id-type="pmcid">PMC2696292</pub-id></mixed-citation></ref><ref id="cit0006"><label>6.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>McHugh</surname><given-names>RK</given-names></string-name>, <string-name name-style="western"><surname>Hearon</surname><given-names>BA</given-names></string-name>, <string-name name-style="western"><surname>Otto</surname><given-names>MW</given-names></string-name>. <article-title>Cognitive-behavioral therapy for substance use disorders</article-title>. <source><italic toggle="yes">Psychiatr Clin North Am</italic></source>. <year>2010</year>;<volume>33</volume>(<issue>3</issue>):<fpage>511</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.psc.2010.04.012</pub-id><pub-id pub-id-type="pmid">20599130</pub-id><pub-id pub-id-type="pmcid">PMC2897895</pub-id></mixed-citation></ref><ref id="cit0007"><label>7.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Haviv</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Hasisi</surname><given-names>B</given-names></string-name>. <article-title>Prison addiction program and the role of integrative treatment and program completion on recidivism</article-title>. <source><italic toggle="yes">Int J Offender Ther Comp Criminol</italic></source>. <year>2019</year>;<volume>63</volume>:<fpage>15</fpage>&#8211;<lpage>16</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0306624X19871650</pub-id><pub-id pub-id-type="pmid">31510830</pub-id></mixed-citation></ref><ref id="cit0008"><label>8.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Shoham</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Efodi</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Haviv</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Gross Shader</surname><given-names>C</given-names></string-name>. <article-title>Dropout from treatment and desistance from crime among released prisoners in Jerusalem halfway house for prisoners with substance misuse disorder</article-title>. <source><italic toggle="yes">Int J Offender Ther Comp Criminol</italic></source>. <year>2022</year>;<volume>66</volume>(<issue>10&#8211;11</issue>):<fpage>1109</fpage>&#8211;<lpage>1133</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0306624X211010291</pub-id><pub-id pub-id-type="pmid">33899532</pub-id></mixed-citation></ref><ref id="cit0009"><label>9.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Ligabue</surname><given-names>KP</given-names></string-name>, <string-name name-style="western"><surname>Schuch</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Scherer</surname><given-names>JN</given-names></string-name>, et al. <article-title>Increased cortisol levels are associated with low treatment retention in crack cocaine users</article-title>. <source><italic toggle="yes">Addict Behav</italic></source>. <year>2020</year>;<volume>103</volume>:<fpage>106260</fpage>. doi:<pub-id pub-id-type="doi">10.1016/J.ADDBEH.2019.106260</pub-id><pub-id pub-id-type="pmid">31901885</pub-id></mixed-citation></ref><ref id="cit0010"><label>10.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Stark</surname><given-names>MJ</given-names></string-name>. <article-title>Dropping out of substance abuse treatment: a clinically oriented review</article-title>. <source><italic toggle="yes">Clin Psychol Rev</italic></source>. <year>1992</year>;<volume>12</volume>(<issue>1</issue>):<fpage>93</fpage>&#8211;<lpage>116</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0272-7358(92)90092-M</pub-id></mixed-citation></ref><ref id="cit0011"><label>11.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>L&#243;pez-Go&#241;i</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Fern&#225;ndez-Montalvo</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Arteaga</surname><given-names>A</given-names></string-name>. <article-title>Addiction treatment dropout: exploring patients&#8217; characteristics</article-title>. <source><italic toggle="yes">Am J Addict</italic></source>. <year>2012</year>;<volume>21</volume>(<issue>1</issue>):<fpage>78</fpage>&#8211;<lpage>85</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1521-0391.2011.00188.x</pub-id><pub-id pub-id-type="pmid">22211350</pub-id></mixed-citation></ref><ref id="cit0012"><label>12.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>L&#243;pez-go&#241;i</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Fern&#225;ndez- Montalvo</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Illescas</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Landa</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Lorea</surname><given-names>I</given-names></string-name>. <article-title>Determining socio-demographic predictors of treatment dropout: results in a therapeutic community</article-title>. <source><italic toggle="yes">Int J Soc Welf</italic></source>. <year>2008</year>;<volume>17</volume>(<issue>4</issue>):<fpage>374</fpage>&#8211;<lpage>378</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1468-2397.2008.00584.x</pub-id></mixed-citation></ref><ref id="cit0013"><label>13.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Li</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Puri</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Marsh</surname><given-names>DC</given-names></string-name>, <string-name name-style="western"><surname>Anis</surname><given-names>AH</given-names></string-name>. <article-title>Factors associated with pretreatment and treatment dropouts among clients admitted to medical withdrawal management</article-title>. <source><italic toggle="yes">J Addict Dis</italic></source>. <year>2007</year>;<volume>26</volume>(<issue>3</issue>):<fpage>77</fpage>&#8211;<lpage>85</lpage>. doi:<pub-id pub-id-type="doi">10.1300/J069v26n03_08</pub-id><pub-id pub-id-type="pmid">18018810</pub-id></mixed-citation></ref><ref id="cit0014"><label>14.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Baekeland</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Lundwall</surname><given-names>L</given-names></string-name>. <article-title>Dropping out of treatment: a critical review</article-title>. <source><italic toggle="yes">Psychol Bull</italic></source>. <year>1975</year>;<volume>82</volume>(<issue>5</issue>):<fpage>738</fpage>&#8211;<lpage>783</lpage>. doi:<pub-id pub-id-type="doi">10.1037/h0077132</pub-id><pub-id pub-id-type="pmid">1103201</pub-id></mixed-citation></ref><ref id="cit0015"><label>15.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Darke</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Campbell</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Popple</surname><given-names>G</given-names></string-name>. <article-title>Retention, early dropout and treatment completion among therapeutic community admissions</article-title>. <source><italic toggle="yes">Drug Alcohol Rev</italic></source>. <year>2012</year>;<volume>31</volume>(<issue>1</issue>):<fpage>64</fpage>&#8211;<lpage>71</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1465-3362.2011.00298.x</pub-id><pub-id pub-id-type="pmid">21426420</pub-id></mixed-citation></ref><ref id="cit0016"><label>16.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Andersson</surname><given-names>HW</given-names></string-name>, <string-name name-style="western"><surname>Steinsbekk</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Walderhaug</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Otterholt</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Nordfj&#230;rn</surname><given-names>T</given-names></string-name>. <article-title>Predictors of dropout from inpatient substance use treatment: a prospective cohort study</article-title>. <source><italic toggle="yes">Subst Abuse</italic></source>. <year>2018</year>;<volume>12</volume>:<fpage>1178221818760551</fpage>. doi:<pub-id pub-id-type="doi">10.1177/1178221818760551</pub-id><pub-id pub-id-type="pmid">29531472</pub-id><pub-id pub-id-type="pmcid">PMC5843095</pub-id></mixed-citation></ref><ref id="cit0017"><label>17.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Brorson</surname><given-names>HH</given-names></string-name>, <string-name name-style="western"><surname>Ajo Arnevik</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Rand-Hendriksen</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Duckert</surname><given-names>F</given-names></string-name>. <article-title>Drop-out from addiction treatment: a systematic review of risk factors</article-title>. <source><italic toggle="yes">Clin Psychol Rev</italic></source>. <year>2013</year>;<volume>33</volume>(<issue>8</issue>):<fpage>1010</fpage>&#8211;<lpage>1024</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cpr.2013.07.007</pub-id><pub-id pub-id-type="pmid">24029221</pub-id></mixed-citation></ref><ref id="cit0018"><label>18.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Andersson</surname><given-names>HW</given-names></string-name>, <string-name name-style="western"><surname>Otterholt</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Gr&#229;we</surname><given-names>RW</given-names></string-name>. <article-title>Patient satisfaction with treatments and outcomes in residential addiction institutions</article-title>. <source><italic toggle="yes">Nord Stud Alcohol Drugs</italic></source>. <year>2017</year>;<volume>34</volume>(<issue>5</issue>):<fpage>375</fpage>&#8211;<lpage>384</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1455072517718456</pub-id><pub-id pub-id-type="pmcid">PMC7450857</pub-id><pub-id pub-id-type="pmid">32934499</pub-id></mixed-citation></ref><ref id="cit0019"><label>19.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Brorson</surname><given-names>HH</given-names></string-name>, <string-name name-style="western"><surname>Arnevik</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>Rand</surname><given-names>K</given-names></string-name>. <article-title>Predicting dropout from inpatient substance use disorder treatment: a prospective validation study of the OQ-analyst</article-title>. <source><italic toggle="yes">Subst Abuse</italic></source>. <year>2019</year>;<volume>13</volume>. doi:<pub-id pub-id-type="doi">10.1177/1178221819866181</pub-id><pub-id pub-id-type="pmcid">PMC6698986</pub-id><pub-id pub-id-type="pmid">31452601</pub-id></mixed-citation></ref><ref id="cit0020"><label>20.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Lintzeris</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Monds</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Rivas</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Leung</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Withall</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Draper</surname><given-names>B</given-names></string-name>. <article-title>The Australian treatment outcomes profile instrument as a clinical tool for older alcohol and other drug clients: a validation study</article-title>. <source><italic toggle="yes">Drug Alcohol Rev</italic></source>. <year>2016</year>;<volume>35</volume>:<fpage>6</fpage>. doi:<pub-id pub-id-type="doi">10.1111/dar.12393</pub-id><pub-id pub-id-type="pmid">27072851</pub-id></mixed-citation></ref><ref id="cit0021"><label>21.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Campbell</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hemsley</surname><given-names>S</given-names></string-name>. <article-title>Outcome rating scale and session rating scale in psychological practice: clinical utility of ultra-brief measures</article-title>. <source><italic toggle="yes">Clin Psychol</italic></source>. <year>2009</year>;<volume>13</volume>(<issue>1</issue>):<fpage>1</fpage>&#8211;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1080/13284200802676391</pub-id></mixed-citation></ref><ref id="cit0022"><label>22.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Lambert</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Hansen</surname><given-names>NB</given-names></string-name>, <string-name name-style="western"><surname>Finch</surname><given-names>AE</given-names></string-name>. <article-title>Patient-focused research: using patient outcome data to enhance treatment effects</article-title>. <source><italic toggle="yes">J Consult Clin Psychol</italic></source>. <year>2001</year>;<volume>69</volume>(<issue>2</issue>):<fpage>2</fpage>. doi:<pub-id pub-id-type="doi">10.1037/0022-006X.69.2.159</pub-id><pub-id pub-id-type="pmid">11393594</pub-id></mixed-citation></ref><ref id="cit0023"><label>23.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Engel</surname><given-names>GL</given-names></string-name>. <article-title>The need for a new medical model: a challenge for biomedicine</article-title>. <source><italic toggle="yes">Science</italic></source>. <year>1977</year>;<volume>196</volume>(<issue>4286</issue>):<fpage>129</fpage>&#8211;<lpage>196</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.847460</pub-id><pub-id pub-id-type="pmid">847460</pub-id></mixed-citation></ref><ref id="cit0024"><label>24.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Stallvik</surname><given-names>M</given-names></string-name>. <article-title>Biopsykososial tiln&#230;rming til rusavhengighet</article-title>. <source><italic toggle="yes">Rusfag</italic></source>. <year>2011</year>;<volume>1</volume>:<fpage>105</fpage>&#8211;<lpage>112</lpage>.</mixed-citation></ref><ref id="cit0025"><label>25.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Marlatt</surname><given-names>GA</given-names></string-name>, <string-name name-style="western"><surname>Baer</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Donovan</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Kivlahan</surname><given-names>DR</given-names></string-name>. <article-title>Addictive behaviors: etiology and treatment</article-title>. <source><italic toggle="yes">Ann Rev Psychol</italic></source>. <year>1988</year>;<volume>39</volume>:<fpage>223</fpage>&#8211;<lpage>252</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.ps.39.020188.001255</pub-id><pub-id pub-id-type="pmid">3278676</pub-id></mixed-citation></ref><ref id="cit0026"><label>26.</label><mixed-citation publication-type="book"><string-name name-style="western"><surname>Volpicelli</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Pettinati</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>McLellan</surname><given-names>HM</given-names></string-name>, et al. <part-title>The biopsychosocial understanding of addiction</part-title>. In: <source><italic toggle="yes">Combining Medication and Psychosocial Treatments for Addictions: The BRENDA Approach</italic></source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Guilford Press</publisher-name>; <year>2001</year>:<fpage>3</fpage>&#8211;<lpage>15</lpage>.</mixed-citation></ref><ref id="cit0027"><label>27.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Daughters</surname><given-names>SB</given-names></string-name>, <string-name name-style="western"><surname>Richards</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Gorka</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Sinha</surname><given-names>R</given-names></string-name>. <article-title>HPA axis response to psychological stress and treatment retention in residential substance abuse treatment: a prospective study</article-title>. <source><italic toggle="yes">Drug Alcohol Depend</italic></source>. <year>2009</year>;<volume>105</volume>(<issue>3</issue>):<fpage>202</fpage>&#8211;<lpage>208</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.drugalcdep.2009.06.026</pub-id><pub-id pub-id-type="pmid">19713052</pub-id><pub-id pub-id-type="pmcid">PMC3774292</pub-id></mixed-citation></ref><ref id="cit0028"><label>28.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Daughters</surname><given-names>SB</given-names></string-name>, <string-name name-style="western"><surname>Lejuez</surname><given-names>CW</given-names></string-name>, <string-name name-style="western"><surname>Bornovalova</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Kahler</surname><given-names>CW</given-names></string-name>, <string-name name-style="western"><surname>Strong</surname><given-names>DR</given-names></string-name>, <string-name name-style="western"><surname>Brown</surname><given-names>RA</given-names></string-name>. <article-title>Distress tolerance as a predictor of early treatment dropout in a residential substance abuse treatment facility</article-title>. <source><italic toggle="yes">J Abnorm Psychol</italic></source>. <year>2005</year>;<volume>114</volume>(<issue>4</issue>):<fpage>729</fpage>&#8211;<lpage>734</lpage>. doi:<pub-id pub-id-type="doi">10.1037/0021-843X.114.4.729</pub-id><pub-id pub-id-type="pmid">16351393</pub-id></mixed-citation></ref><ref id="cit0029"><label>29.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Rozynko</surname><given-names>VV</given-names></string-name>, <string-name name-style="western"><surname>Stein</surname><given-names>KB</given-names></string-name>. <article-title>Social and psychological factors associated with length of stay in a drug treatment facility</article-title>. <source><italic toggle="yes">Int J Addict</italic></source>. <year>1974</year>;<volume>9</volume>(<issue>6</issue>):<fpage>873</fpage>&#8211;<lpage>878</lpage>. doi:<pub-id pub-id-type="doi">10.3109/10826087409022181</pub-id><pub-id pub-id-type="pmid">4155701</pub-id></mixed-citation></ref><ref id="cit0030"><label>30.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Dziurkowska</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Wesolowski</surname><given-names>M</given-names></string-name>. <article-title>Cortisol as a biomarker of mental disorder severity</article-title>. <source><italic toggle="yes">J Clin Med</italic></source>. <year>2021</year>;<volume>10</volume>(<issue>21</issue>):<fpage>5204</fpage>. doi:<pub-id pub-id-type="doi">10.3390/jcm10215204</pub-id><pub-id pub-id-type="pmid">34768724</pub-id><pub-id pub-id-type="pmcid">PMC8584322</pub-id></mixed-citation></ref><ref id="cit0031"><label>31.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Hellhammer</surname><given-names>DH</given-names></string-name>, <string-name name-style="western"><surname>W&#252;st</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Kudielka</surname><given-names>BM</given-names></string-name>. <article-title>Salivary cortisol as a biomarker in stress research</article-title>. <source><italic toggle="yes">Psychoneuroendocrinology</italic></source>. <year>2009</year>;<volume>34</volume>(<issue>2</issue>):<fpage>163</fpage>&#8211;<lpage>171</lpage>. doi:<pub-id pub-id-type="doi">10.1016/J.PSYNEUEN.2008.10.026</pub-id><pub-id pub-id-type="pmid">19095358</pub-id></mixed-citation></ref><ref id="cit0032"><label>32.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Junghanns</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Tietz</surname><given-names>U</given-names></string-name>, <string-name name-style="western"><surname>Dibbelt</surname><given-names>L</given-names></string-name>, et al. <article-title>Attenuated salivary cortisol secretion under cue exposure is associated with early relapse</article-title>. <source><italic toggle="yes">Alcohol Alcohol</italic></source>. <year>2005</year>;<volume>40</volume>(<issue>1</issue>):<fpage>80</fpage>&#8211;<lpage>85</lpage>. doi:<pub-id pub-id-type="doi">10.1093/ALCALC/AGH107</pub-id><pub-id pub-id-type="pmid">15550447</pub-id></mixed-citation></ref><ref id="cit0033"><label>33.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Moss</surname><given-names>HB</given-names></string-name>, <string-name name-style="western"><surname>Vanyukov</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Martin</surname><given-names>CS</given-names></string-name>. <article-title>Salivary cortisol responses and the risk for substance abuse in prepubertal boys</article-title>. <source><italic toggle="yes">Biol Psychiatry</italic></source>. <year>1995</year>;<volume>38</volume>(<issue>8</issue>):<fpage>547</fpage>&#8211;<lpage>555</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0006-3223(94)00382-D</pub-id><pub-id pub-id-type="pmid">8562667</pub-id></mixed-citation></ref><ref id="cit0034"><label>34.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Szabo</surname><given-names>YZ</given-names></string-name>, <string-name name-style="western"><surname>Breeding</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Hejl</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Guleria</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>Nelson</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Zambrano-Vazquez</surname><given-names>L</given-names></string-name>. <article-title>Cortisol as a biomarker of alcohol use in combat veterans: a literature review and framework for future research</article-title>. <source><italic toggle="yes">J Dual Diagn</italic></source>. <year>2020</year>;<volume>16</volume>(<issue>3</issue>):<fpage>322</fpage>&#8211;<lpage>335</lpage>. doi:<pub-id pub-id-type="doi">10.1080/15504263.2020.1771504</pub-id><pub-id pub-id-type="pmid">32493131</pub-id><pub-id pub-id-type="pmcid">PMC7483986</pub-id></mixed-citation></ref><ref id="cit0035"><label>35.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Lovallo</surname><given-names>WR</given-names></string-name>, <string-name name-style="western"><surname>Cohoon</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Sorocco</surname><given-names>KH</given-names></string-name>. <article-title>Early-life adversity and blunted stress reactivity as predictors of alcohol and drug use in persons with COMT (rs4680) Val158Met genotypes</article-title>. <source><italic toggle="yes">Alcohol Clin Exp Res</italic></source>. <year>2019</year>;<volume>43</volume>(<issue>7</issue>):<fpage>1519</fpage>&#8211;<lpage>1527</lpage>. doi:<pub-id pub-id-type="doi">10.1111/acer.14079</pub-id><pub-id pub-id-type="pmid">31150143</pub-id><pub-id pub-id-type="pmcid">PMC6602827</pub-id></mixed-citation></ref><ref id="cit0036"><label>36.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Adinoff</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Junghanns</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Kiefer</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Krishnan-Sarin</surname><given-names>S</given-names></string-name>. <article-title>Suppression of the HPA axis stress-response: implications for relapse</article-title>. <source><italic toggle="yes">Alcohol Clin Exp Res</italic></source>. <year>2005</year>;<volume>29</volume>(<issue>7</issue>):<fpage>1351</fpage>. doi:<pub-id pub-id-type="doi">10.1097/01.ALC.0000176356.97620.84</pub-id><pub-id pub-id-type="pmid">16088999</pub-id><pub-id pub-id-type="pmcid">PMC2584966</pub-id></mixed-citation></ref><ref id="cit0037"><label>37.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Sinha</surname><given-names>R</given-names></string-name>. <article-title>New findings on biological factors predicting addiction relapse vulnerability</article-title>. <source><italic toggle="yes">Curr Psychiatry Rep</italic></source>. <year>2011</year>;<volume>13</volume>(<issue>5</issue>):<fpage>398</fpage>&#8211;<lpage>405</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11920-011-0224-0</pub-id><pub-id pub-id-type="pmid">21792580</pub-id><pub-id pub-id-type="pmcid">PMC3674771</pub-id></mixed-citation></ref><ref id="cit0038"><label>38.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Jaremko</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Sterling</surname><given-names>RC</given-names></string-name>, <string-name name-style="western"><surname>van Bockstaele</surname><given-names>EJ</given-names></string-name>. <article-title>Psychological and physiological stress negatively impacts early engagement and retention of opioid-dependent individuals on methadone maintenance</article-title>. <source><italic toggle="yes">J Subst Abuse Treat</italic></source>. <year>2015</year>;<volume>48</volume>(<issue>1</issue>):<fpage>117</fpage>&#8211;<lpage>127</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jsat.2014.08.006</pub-id><pub-id pub-id-type="pmid">25239858</pub-id><pub-id pub-id-type="pmcid">PMC4250337</pub-id></mixed-citation></ref><ref id="cit0039"><label>39.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Sinha</surname><given-names>R</given-names></string-name>. <article-title>How does stress increase risk of drug abuse and relapse?</article-title><source><italic toggle="yes">Psychopharmacology</italic></source>. <year>2001</year>;<volume>158</volume>(<issue>4</issue>):<fpage>343</fpage>&#8211;<lpage>359</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s002130100917</pub-id><pub-id pub-id-type="pmid">11797055</pub-id></mixed-citation></ref><ref id="cit0040"><label>40.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Ali</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Green</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Daughters</surname><given-names>SB</given-names></string-name>, <string-name name-style="western"><surname>Lejuez</surname><given-names>CW</given-names></string-name>. <article-title>Distress tolerance interacts with circumstances, motivation, and readiness to predict substance abuse treatment retention</article-title>. <source><italic toggle="yes">Addict Behav</italic></source>. <year>2017</year>;<volume>73</volume>:<fpage>99</fpage>&#8211;<lpage>104</lpage>. <comment>PMID: 28500908; PMCID: PMC5542844</comment>. doi:<pub-id pub-id-type="doi">10.1016/j.addbeh.2017.04.016</pub-id><pub-id pub-id-type="pmid">28500908</pub-id><pub-id pub-id-type="pmcid">PMC5542844</pub-id></mixed-citation></ref><ref id="cit0041"><label>41.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Gragera-Martinez</surname><given-names>&#193;</given-names></string-name>, <string-name name-style="western"><surname>Le&#243;n-Justel</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Arriero</surname><given-names>LH</given-names></string-name>, <string-name name-style="western"><surname>Alor</surname><given-names>FB</given-names></string-name>, <string-name name-style="western"><surname>Vazquez</surname><given-names>IR</given-names></string-name>. <article-title>Cortisol in saliva to predict relapse in patients addicted to cocaine use</article-title>. <source><italic toggle="yes">Clin Chim Acta</italic></source>. <year>2019</year>;<volume>493</volume>:<fpage>S328</fpage>&#8211;<lpage>S329</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cca.2019.03.712</pub-id></mixed-citation></ref><ref id="cit0042"><label>42.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Sinha</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Garcia</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Paliwal</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Kreek</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Rounsaville</surname><given-names>BJ</given-names></string-name>. <article-title>Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes</article-title>. <source><italic toggle="yes">Arch Gen Psychiatry</italic></source>. <year>2006</year>;<volume>63</volume>(<issue>3</issue>):<fpage>324</fpage>&#8211;<lpage>331</lpage>. doi:<pub-id pub-id-type="doi">10.1001/archpsyc.63.3.324</pub-id><pub-id pub-id-type="pmid">16520439</pub-id></mixed-citation></ref><ref id="cit0043"><label>43.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Fox</surname><given-names>HC</given-names></string-name>, <string-name name-style="western"><surname>Jackson</surname><given-names>ED</given-names></string-name>, <string-name name-style="western"><surname>Sinha</surname><given-names>R</given-names></string-name>. <article-title>Elevated cortisol and learning and memory deficits in cocaine dependent individuals: relationship to relapse outcomes</article-title>. <source><italic toggle="yes">Psychoneuroendocrinology</italic></source>. <year>2009</year>;<volume>34</volume>(<issue>8</issue>):<fpage>1198</fpage>&#8211;<lpage>1207</lpage>. doi:<pub-id pub-id-type="doi">10.1016/J.PSYNEUEN.2009.03.007</pub-id><pub-id pub-id-type="pmid">19375236</pub-id><pub-id pub-id-type="pmcid">PMC2746363</pub-id></mixed-citation></ref><ref id="cit0044"><label>44.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Contoreggi</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Herning</surname><given-names>RI</given-names></string-name>, <string-name name-style="western"><surname>Koeppl</surname><given-names>B</given-names></string-name>, et al. <article-title>Treatment-seeking inpatient cocaine abusers show hypothalamic dysregulation of both basal prolactin and cortisol secretion</article-title>. <source><italic toggle="yes">Neuroendocrinology</italic></source>. <year>2003</year>;<volume>78</volume>(<issue>3</issue>):<fpage>154</fpage>&#8211;<lpage>162</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000072797</pub-id><pub-id pub-id-type="pmid">14512708</pub-id></mixed-citation></ref><ref id="cit0045"><label>45.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Wisniewski</surname><given-names>AB</given-names></string-name>, <string-name name-style="western"><surname>Brown</surname><given-names>TT</given-names></string-name>, <string-name name-style="western"><surname>John</surname><given-names>M</given-names></string-name>, et al. <article-title>Cortisol levels and depression in men and women using heroin and cocaine. Auernhammer Brockmeyer Brown Brown Cami Cooper Facchinetti Golub Golub Greene Heim Jiang Kuhn Laudat Leserman Linkowski Lortholary Martin Mayo Nock Plotsky Rubin Varghese Villette Wisniewski Wizemann Young Zhou A, ed</article-title>. <source><italic toggle="yes">Psychoneuroendocrinology</italic></source>. <year>2006</year>;<volume>31</volume>(<issue>2</issue>):<fpage>250</fpage>&#8211;<lpage>255</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.psyneuen.2005.08.002</pub-id><pub-id pub-id-type="pmid">16157457</pub-id></mixed-citation></ref><ref id="cit0046"><label>46.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Rao</surname><given-names>U</given-names></string-name>, <string-name name-style="western"><surname>Hammen</surname><given-names>CL</given-names></string-name>, <string-name name-style="western"><surname>Poland</surname><given-names>RE</given-names></string-name>. <article-title>Mechanisms underlying the comorbidity between depressive and addictive disorders in adolescents: interactions between stress and HPA activity</article-title>. <source><italic toggle="yes">Am J Psychiatry</italic></source>. <year>2009</year>;<volume>166</volume>(<issue>3</issue>):<fpage>361</fpage>&#8211;<lpage>369</lpage>. doi:<pub-id pub-id-type="doi">10.1176/appi.ajp.2008.08030412</pub-id><pub-id pub-id-type="pmid">19223436</pub-id><pub-id pub-id-type="pmcid">PMC2770585</pub-id></mixed-citation></ref><ref id="cit0047"><label>47.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Adinoff</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Iranmanesh</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Veldhuis</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Fisher</surname><given-names>L</given-names></string-name>. <article-title>Disturbances of the stress response: the role of the HPA axis during alcohol withdrawal and abstinence</article-title>. <source><italic toggle="yes">Alcohol Health Res World</italic></source>. <year>1998</year>;<volume>22</volume>(<issue>1</issue>):<fpage>67</fpage>.<pub-id pub-id-type="pmid">15706736</pub-id><pub-id pub-id-type="pmcid">PMC6761816</pub-id></mixed-citation></ref><ref id="cit0048"><label>48.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Adinoff</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Krebaum</surname><given-names>SR</given-names></string-name>, <string-name name-style="western"><surname>Chandler</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Ye</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Brown</surname><given-names>MB</given-names></string-name>, <string-name name-style="western"><surname>Williams</surname><given-names>MJ</given-names></string-name>. <article-title>Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent men, part 1: adrenocortical and pituitary glucocorticoid responsiveness</article-title>. <source><italic toggle="yes">Alcohol Clin Exp Res</italic></source>. <year>2005</year>;<volume>29</volume>(<issue>4</issue>):<fpage>517</fpage>&#8211;<lpage>527</lpage>. doi:<pub-id pub-id-type="doi">10.1097/01.ALC.0000158940.05529.0A</pub-id><pub-id pub-id-type="pmid">15834216</pub-id><pub-id pub-id-type="pmcid">PMC2584970</pub-id></mixed-citation></ref><ref id="cit0049"><label>49.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Cuttler</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Spradlin</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Nusbaum</surname><given-names>AT</given-names></string-name>, <string-name name-style="western"><surname>Whitney</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Hinson</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>McLaughlin</surname><given-names>RJ</given-names></string-name>. <article-title>Blunted stress reactivity in chronic cannabis users</article-title>. <source><italic toggle="yes">Psychopharmacology</italic></source>. <year>2017</year>;<volume>234</volume>(<issue>15</issue>):<fpage>2299</fpage>&#8211;<lpage>2309</lpage>. doi:<pub-id pub-id-type="doi">10.1007/S00213-017-4648-Z/FIGURES/5</pub-id><pub-id pub-id-type="pmid">28567696</pub-id></mixed-citation></ref><ref id="cit0050"><label>50.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Stephens</surname><given-names>MAC</given-names></string-name>, <string-name name-style="western"><surname>Wand</surname><given-names>G</given-names></string-name>. <article-title>Stress and the HPA Axis Role of Glucocorticoids in Alcohol Dependence</article-title>. <source><italic toggle="yes">Alcohol res</italic></source>. <year>2012</year>;<volume>34</volume>(<issue>4</issue>):<fpage>468</fpage>&#8211;<lpage>483</lpage>.<pub-id pub-id-type="pmid">23584113</pub-id><pub-id pub-id-type="pmcid">PMC3860380</pub-id></mixed-citation></ref><ref id="cit0051"><label>51.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Peles</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Malik</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Altman</surname><given-names>Y</given-names></string-name>, et al. <article-title>Stress indices in methadone maintenance treatment - cross sectional and follow up study</article-title>. <source><italic toggle="yes">Psychiatry Res</italic></source>. <year>2020</year>;<volume>291</volume>:<fpage>113218</fpage>. doi:<pub-id pub-id-type="doi">10.1016/J.PSYCHRES.2020.113218</pub-id><pub-id pub-id-type="pmid">32544714</pub-id></mixed-citation></ref><ref id="cit0052"><label>52.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>B&#248;hle</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Otterholt</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Bj&#248;rkly</surname><given-names>S</given-names></string-name>. <article-title>Is there an association between salivary cortisol and dropping out of inpatient substance addiction treatments? A prospective repeated measures study</article-title>. <source><italic toggle="yes">Subst Abuse</italic></source>. <year>2022</year>;<volume>16</volume>. doi:<pub-id pub-id-type="doi">10.1177/11782218221106797</pub-id><pub-id pub-id-type="pmcid">PMC9253992</pub-id><pub-id pub-id-type="pmid">35800884</pub-id></mixed-citation></ref><ref id="cit0053"><label>53.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Santucci</surname><given-names>K</given-names></string-name>. <article-title>Psychiatric disease and drug abuse</article-title>. <source><italic toggle="yes">Curr Opin Pediatr</italic></source>. <year>2012</year>;<volume>24</volume>(<issue>2</issue>):<fpage>233</fpage>&#8211;<lpage>237</lpage>. doi:<pub-id pub-id-type="doi">10.1097/MOP.0B013E3283504FBF</pub-id><pub-id pub-id-type="pmid">22327950</pub-id></mixed-citation></ref><ref id="cit0054"><label>54.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Burdzovic Andreas</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lauritzen</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Nordfj&#230;rn</surname><given-names>T</given-names></string-name>. <article-title>Co-occurrence between mental distress and poly-drug use: a ten year prospective study of patients from substance abuse treatment</article-title>. <source><italic toggle="yes">Addict Behav</italic></source>. <year>2015</year>;<volume>48</volume>:<fpage>71</fpage>&#8211;<lpage>78</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.addbeh.2015.05.001</pub-id><pub-id pub-id-type="pmid">26004857</pub-id></mixed-citation></ref><ref id="cit0055"><label>55.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>L&#248;berg</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Helle</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Nygard</surname><given-names>M</given-names></string-name>, et al. <article-title>The cannabis pathway to non-affective psychosis may reflect less neurobiological vulnerability</article-title>. <source><italic toggle="yes">Front Psychiatry</italic></source>. <year>2014</year>;<volume>5</volume>(<issue>OCT</issue>):<fpage>159</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fpsyt.2014.00159</pub-id><pub-id pub-id-type="pmid">25477825</pub-id><pub-id pub-id-type="pmcid">PMC4235385</pub-id></mixed-citation></ref><ref id="cit0056"><label>56.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Bramness</surname><given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Gundersen</surname><given-names>&#216;H</given-names></string-name>, <string-name name-style="western"><surname>Guterstam</surname><given-names>J</given-names></string-name>, et al. <article-title>Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable?</article-title><source><italic toggle="yes">BMC Psychiatry</italic></source>. <year>2012</year>;<volume>12</volume>(<issue>1</issue>):<fpage>1</fpage>&#8211;<lpage>7</lpage>. doi:<pub-id pub-id-type="doi">10.1186/1471-244X-12-221/FIGURES/1</pub-id><pub-id pub-id-type="pmid">23216941</pub-id><pub-id pub-id-type="pmcid">PMC3554477</pub-id></mixed-citation></ref><ref id="cit0057"><label>57.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Landheim</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Bakken</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Vaglum</surname><given-names>P</given-names></string-name>. <article-title>Impact of comorbid psychiatric disorders on the outcome of substance abusers: a six year prospective follow-up in two Norwegian counties</article-title>. <source><italic toggle="yes">BMC Psychiatry</italic></source>. <year>2006</year>;<volume>6</volume>(<issue>1</issue>). doi:<pub-id pub-id-type="doi">10.1186/1471-244X-6-44</pub-id><pub-id pub-id-type="pmcid">PMC1626456</pub-id><pub-id pub-id-type="pmid">17054775</pub-id></mixed-citation></ref><ref id="cit0058"><label>58.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Simpson</surname><given-names>DD</given-names></string-name>, <string-name name-style="western"><surname>Joe</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Rowan-Szal</surname><given-names>GA</given-names></string-name>, <string-name name-style="western"><surname>Greener</surname><given-names>JM</given-names></string-name>. <article-title>Drug abuse treatment process components that improve retention outcome assessment of correctional treatment view project TERESA view project</article-title>. <source><italic toggle="yes">J Subst Abuse Treat</italic></source>. <year>1997</year>;<volume>14</volume>(<issue>6</issue>):<fpage>565</fpage>&#8211;<lpage>572</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0740-5472(97)00181-5</pub-id><pub-id pub-id-type="pmid">9437628</pub-id></mixed-citation></ref><ref id="cit0059"><label>59.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Hassel</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Nordfjaern</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Hagen</surname><given-names>R</given-names></string-name>. <article-title>Journal of substance use psychological and interpersonal distress among patients with substance use disorders: are these factors associated with continued drug use and do they change during treatment?) Psychological and interpersonal distress among patients with substance use disorders: are these factors associated with continued drug use and do they change during treatment?</article-title><source><italic toggle="yes">J Subst Use</italic></source>. <year>2012</year>;<volume>18</volume>(<issue>5</issue>):<fpage>363</fpage>&#8211;<lpage>376</lpage>. doi:<pub-id pub-id-type="doi">10.3109/14659891.2012.685122</pub-id></mixed-citation></ref><ref id="cit0060"><label>60.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Ormbostad</surname><given-names>HAK</given-names></string-name>, <string-name name-style="western"><surname>Otterholt</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Stallvik</surname><given-names>M</given-names></string-name>. <article-title>Investigating patients&#8217; perceptions of residential substance use treatment. Is drop out a deliberate or impulsive act?</article-title><source><italic toggle="yes">J Soc Work Pract Addict</italic></source>. <year>2021</year>;<volume>21</volume>(<issue>3</issue>):<fpage>255</fpage>&#8211;<lpage>272</lpage>. doi:<pub-id pub-id-type="doi">10.1080/1533256X.2021.1933850</pub-id></mixed-citation></ref><ref id="cit0061"><label>61.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Adinoff</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Martin</surname><given-names>PR</given-names></string-name>, <string-name name-style="western"><surname>Bone</surname><given-names>GHA</given-names></string-name>, et al. <article-title>Hypothalamic-pituitary-adrenal axis functioning and cerebrospinal fluid corticotropin releasing hormone and corticotropin levels in alcoholics after recent and long-term abstinence</article-title>. <source><italic toggle="yes">Arch Gen Psychiatry</italic></source>. <year>1990</year>;<volume>47</volume>(<issue>4</issue>):<fpage>325</fpage>&#8211;<lpage>330</lpage>. doi:<pub-id pub-id-type="doi">10.1001/ARCHPSYC.1990.01810160025004</pub-id><pub-id pub-id-type="pmid">2157379</pub-id></mixed-citation></ref><ref id="cit0062"><label>62.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Carr</surname><given-names>WA</given-names></string-name>, <string-name name-style="western"><surname>Ball</surname><given-names>SA</given-names></string-name>. <article-title>Predictors and treatment outcomes of perceived ward atmosphere among therapeutic community residents</article-title>. <source><italic toggle="yes">J Subst Abuse Treat</italic></source>. <year>2014</year>;<volume>46</volume>(<issue>5</issue>):<fpage>567</fpage>&#8211;<lpage>573</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jsat.2014.01.003</pub-id><pub-id pub-id-type="pmid">24560437</pub-id></mixed-citation></ref><ref id="cit0063"><label>63.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Verinis</surname><given-names>JS</given-names></string-name>. <article-title>Ward atmosphere as a factor in irregular discharge from an alcohol rehabilitation unit</article-title>. <source><italic toggle="yes">Int J Addict</italic></source>. <year>1983</year>;<volume>18</volume>(<issue>6</issue>):<fpage>895</fpage>&#8211;<lpage>899</lpage>. doi:<pub-id pub-id-type="doi">10.3109/10826088309033057</pub-id><pub-id pub-id-type="pmid">6629587</pub-id></mixed-citation></ref><ref id="cit0064"><label>64.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Fischer</surname><given-names>J</given-names></string-name>. <article-title>The relationship between alcoholic patients&#8217; milieu perception and measures of their drinking during a brief follow-up period</article-title>. <source><italic toggle="yes">Int J Addict</italic></source>. <year>2009</year>;<volume>14</volume>(<issue>8</issue>):<fpage>1151</fpage>&#8211;<lpage>1156</lpage>. doi:<pub-id pub-id-type="doi">10.3109/10826087909048704</pub-id><pub-id pub-id-type="pmid">536061</pub-id></mixed-citation></ref><ref id="cit0065"><label>65.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Beckwith</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Best</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Dingle</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Perryman</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Lubman</surname><given-names>D</given-names></string-name>. <article-title>Alcoholism treatment quarterly predictors of flexibility in social identity among people entering a therapeutic community for substance abuse</article-title>. <source><italic toggle="yes">Alcohol Treat Q</italic></source>. <year>2015</year>;<volume>33</volume>(<issue>1</issue>):<fpage>93</fpage>&#8211;<lpage>104</lpage>. doi:<pub-id pub-id-type="doi">10.1080/07347324.2015.982465</pub-id></mixed-citation></ref><ref id="cit0066"><label>66.</label><mixed-citation publication-type="book"><string-name name-style="western"><surname>Moos</surname><given-names>RH</given-names></string-name>. <source><italic toggle="yes">Ward Atmosphere Scale Manual (A Social Climate Scale)</italic></source>. <publisher-loc>Paolo Alto</publisher-loc>: <publisher-name>Consulting Psychologists Press</publisher-name>; <year>1974</year>.</mixed-citation></ref><ref id="cit0067"><label>67.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Moos</surname><given-names>RH</given-names></string-name>, <string-name name-style="western"><surname>Shelton</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Petty</surname><given-names>C</given-names></string-name>. <article-title>Perceived ward climate and treatment outcome</article-title>. <source><italic toggle="yes">J Abnorm Psychol</italic></source>. <year>1973</year>;<volume>82</volume>(<issue>2</issue>):<fpage>291</fpage>&#8211;<lpage>298</lpage>. doi:<pub-id pub-id-type="doi">10.1037/h0035184</pub-id><pub-id pub-id-type="pmid">4754370</pub-id></mixed-citation></ref><ref id="cit0068"><label>68.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>McKellar</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kelly</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Harris</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Moos</surname><given-names>R</given-names></string-name>. <article-title>Pretreatment and during treatment risk factors for dropout among patients with substance use disorders</article-title>. <source><italic toggle="yes">Addict Behav</italic></source>. <year>2006</year>;<volume>31</volume>(<issue>3</issue>):<fpage>450</fpage>&#8211;<lpage>460</lpage>. doi:<pub-id pub-id-type="doi">10.1016/J.ADDBEH.2005.05.024</pub-id><pub-id pub-id-type="pmid">15979244</pub-id></mixed-citation></ref><ref id="cit0069"><label>69.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Marrero</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Robles</surname><given-names>RR</given-names></string-name>, <string-name name-style="western"><surname>Col&#243;n</surname><given-names>HM</given-names></string-name>, et al. <article-title>Factors associated with drug treatment dropout among injection drug users in Puerto Rico</article-title>. <source><italic toggle="yes">Addict Behav</italic></source>. <year>2005</year>;<volume>30</volume>(<issue>2</issue>):<fpage>397</fpage>&#8211;<lpage>402</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.addbeh.2004.05.024</pub-id><pub-id pub-id-type="pmid">15621413</pub-id></mixed-citation></ref><ref id="cit0070"><label>70.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Taxman</surname><given-names>FS</given-names></string-name>, <string-name name-style="western"><surname>Thanner</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Weisburd</surname><given-names>D</given-names></string-name>. <article-title>Risk, Need, and Responsivity (RNR): it all depends</article-title>. <source><italic toggle="yes">Crime Delinq</italic></source>. <year>2006</year>;<volume>52</volume>(<issue>1</issue>):<fpage>28</fpage>&#8211;<lpage>51</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0011128705281754</pub-id><pub-id pub-id-type="pmid">18542715</pub-id><pub-id pub-id-type="pmcid">PMC2423325</pub-id></mixed-citation></ref><ref id="cit0071"><label>71.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Stallvik</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Gastfriend</surname><given-names>DR</given-names></string-name>, <string-name name-style="western"><surname>Nordahl</surname><given-names>HM</given-names></string-name>. <article-title>Matching patients with substance use disorder to optimal level of care with the ASAM criteria software</article-title>. <source><italic toggle="yes">J Subst Use</italic></source>. <year>2014</year>;<volume>20</volume>(<issue>6</issue>):<fpage>389</fpage>&#8211;<lpage>398</lpage>. doi:<pub-id pub-id-type="doi">10.3109/14659891.2014.934305</pub-id></mixed-citation></ref><ref id="cit0072"><label>72.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Lappan</surname><given-names>SN</given-names></string-name>, <string-name name-style="western"><surname>Brown</surname><given-names>AW</given-names></string-name>, <string-name name-style="western"><surname>Hendricks</surname><given-names>PS</given-names></string-name>. <article-title>Dropout rates of in-person psychosocial substance use disorder treatments: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">Addiction</italic></source>. <year>2020</year>;<volume>115</volume>(<issue>2</issue>):<fpage>201</fpage>&#8211;<lpage>217</lpage>. doi:<pub-id pub-id-type="doi">10.1111/ADD.14793</pub-id><pub-id pub-id-type="pmid">31454123</pub-id></mixed-citation></ref><ref id="cit0073"><label>73.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Miller</surname><given-names>WR</given-names></string-name>. <article-title>Motivation for treatment. A review with special emphasis on alcoholism</article-title>. <source><italic toggle="yes">Psychol Bull</italic></source>. <year>1985</year>;<volume>98</volume>(<issue>1</issue>):<fpage>84</fpage>&#8211;<lpage>107</lpage>. doi:<pub-id pub-id-type="doi">10.1037/0033-2909.98.1.84</pub-id><pub-id pub-id-type="pmid">3898175</pub-id></mixed-citation></ref><ref id="cit0074"><label>74.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Simpson</surname><given-names>DD</given-names></string-name>, <string-name name-style="western"><surname>Joe</surname><given-names>GW</given-names></string-name>. <article-title>Motivation as a predictor of early dropout from drug abuse treatment</article-title>. <source><italic toggle="yes">Psychotherapy</italic></source>. <year>1993</year>;<volume>30</volume>(<issue>2</issue>):<fpage>357</fpage>&#8211;<lpage>368</lpage>. doi:<pub-id pub-id-type="doi">10.1037/0033-3204.30.2.357</pub-id></mixed-citation></ref><ref id="cit0075"><label>75.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Philips</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Wennberg</surname><given-names>P</given-names></string-name>. <article-title>The importance of therapy motivation for patients with substance use disorders</article-title>. <source><italic toggle="yes">Psychotherapy</italic></source>. <year>2014</year>;<volume>51</volume>(<issue>4</issue>):<fpage>555</fpage>&#8211;<lpage>562</lpage>. doi:<pub-id pub-id-type="doi">10.1037/A0033360</pub-id><pub-id pub-id-type="pmid">24059740</pub-id></mixed-citation></ref><ref id="cit0076"><label>76.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Joe</surname><given-names>GW</given-names></string-name>, <string-name name-style="western"><surname>Simpson</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Broome</surname><given-names>KM</given-names></string-name>. <article-title>Effects of readiness for drug abuse treatment on client retention and assessment of process</article-title>. <source><italic toggle="yes">Addiction</italic></source>. <year>1998</year>;<volume>93</volume>(<issue>8</issue>):<fpage>1177</fpage>&#8211;<lpage>1190</lpage>. doi:<pub-id pub-id-type="doi">10.1080/09652149835008</pub-id><pub-id pub-id-type="pmid">9813899</pub-id></mixed-citation></ref><ref id="cit0077"><label>77.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Sacks</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>McKendrick</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Sacks</surname><given-names>JY</given-names></string-name>, <string-name name-style="western"><surname>Cleland</surname><given-names>CM</given-names></string-name>. <article-title>Modified therapeutic community for co-occurring disorders: single investigator meta-analysis</article-title>. <source><italic toggle="yes">Subst Abuse</italic></source>. <year>2010</year>;<volume>31</volume>(<issue>3</issue>):<fpage>146</fpage>&#8211;<lpage>161</lpage>. doi:<pub-id pub-id-type="doi">10.1080/08897077.2010.495662</pub-id><pub-id pub-id-type="pmcid">PMC3058619</pub-id><pub-id pub-id-type="pmid">20687003</pub-id></mixed-citation></ref><ref id="cit0078"><label>78.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Adam</surname><given-names>EK</given-names></string-name>, <string-name name-style="western"><surname>Kumari</surname><given-names>M</given-names></string-name>. <article-title>Assessing salivary cortisol in large-scale, epidemiological research</article-title>. <source><italic toggle="yes">Psychoneuroendocrinology</italic></source>. <year>2009</year>;<volume>34</volume>(<issue>10</issue>):<fpage>1423</fpage>&#8211;<lpage>1436</lpage>. doi:<pub-id pub-id-type="doi">10.1016/J.PSYNEUEN.2009.06.011</pub-id><pub-id pub-id-type="pmid">19647372</pub-id></mixed-citation></ref><ref id="cit0079"><label>79.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Pruessner</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Kirschbaum</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Meinlschmid</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Hellhammer</surname><given-names>DH</given-names></string-name>. <article-title>Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change</article-title>. <source><italic toggle="yes">Psychoneuroendocrinology</italic></source>. <year>2003</year>;<volume>28</volume>(<issue>7</issue>):<fpage>916</fpage>&#8211;<lpage>931</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0306-4530(02)00108-7</pub-id><pub-id pub-id-type="pmid">12892658</pub-id></mixed-citation></ref><ref id="cit0080"><label>80.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Stalder</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Kirschbaum</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Kudielka</surname><given-names>BM</given-names></string-name>, et al. <article-title>Assessment of the cortisol awakening response: expert consensus guidelines</article-title>. <source><italic toggle="yes">Psychoneuroendocrinology</italic></source>. <year>2016</year>;<volume>63</volume>:<fpage>414</fpage>&#8211;<lpage>432</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.psyneuen.2015.10.010</pub-id><pub-id pub-id-type="pmid">26563991</pub-id></mixed-citation></ref><ref id="cit0081"><label>81.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Nicholson</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Miller</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Schwertz</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Sorokin</surname><given-names>O</given-names></string-name>. <article-title>Gender differences in acculturation, stress, and salivary cortisol response among former soviet immigrants</article-title>. <source><italic toggle="yes">J Immigr Minor Health</italic></source>. <year>2013</year>;<volume>15</volume>(<issue>3</issue>):<fpage>540</fpage>&#8211;<lpage>552</lpage>. doi:<pub-id pub-id-type="doi">10.1007/S10903-012-9752-X/TABLES/3</pub-id><pub-id pub-id-type="pmid">23224773</pub-id></mixed-citation></ref><ref id="cit0082"><label>82.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Dmitrieva</surname><given-names>NO</given-names></string-name>, <string-name name-style="western"><surname>Almeida</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Dmitrieva</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Loken</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Pieper</surname><given-names>CF</given-names></string-name>. <article-title>A day-centered approach to modeling cortisol: diurnal cortisol profiles and their associations among U.S. adults</article-title>. <source><italic toggle="yes">Psychoneuroendocrinology</italic></source>. <year>2013</year>;<volume>38</volume>(<issue>10</issue>):<fpage>2354</fpage>&#8211;<lpage>2365</lpage>. doi:<pub-id pub-id-type="doi">10.1016/J.PSYNEUEN.2013.05.003</pub-id><pub-id pub-id-type="pmid">23770247</pub-id><pub-id pub-id-type="pmcid">PMC3776005</pub-id></mixed-citation></ref><ref id="cit0083"><label>83.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>de Leon</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Melnick</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Kressel</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Jainchill</surname><given-names>N</given-names></string-name>. <article-title>Circumstances, motivation, readiness, and suitability (the CMRS scales): predicting retention in therapeutic community treatment</article-title>. <source><italic toggle="yes">Am J Drug Alcohol Abuse</italic></source>. <year>1994</year>;<volume>20</volume>(<issue>4</issue>):<fpage>495</fpage>&#8211;<lpage>515</lpage>. doi:<pub-id pub-id-type="doi">10.3109/00952999409109186</pub-id><pub-id pub-id-type="pmid">7832182</pub-id></mixed-citation></ref><ref id="cit0084"><label>84.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Derogatis</surname><given-names>LR</given-names></string-name>, <string-name name-style="western"><surname>Lipman</surname><given-names>RS</given-names></string-name>, <string-name name-style="western"><surname>Rickels</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Uhlenhuth</surname><given-names>EH</given-names></string-name>, <string-name name-style="western"><surname>Covi</surname><given-names>L</given-names></string-name>. <article-title>The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory</article-title>. <source><italic toggle="yes">Behav Sci</italic></source>. <year>1974</year>;<volume>19</volume>(<issue>1</issue>):<fpage>1</fpage>&#8211;<lpage>15</lpage>. doi:<pub-id pub-id-type="doi">10.1002/bs.3830190102</pub-id><pub-id pub-id-type="pmid">4808738</pub-id></mixed-citation></ref><ref id="cit0085"><label>85.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Strand</surname><given-names>BH</given-names></string-name>, <string-name name-style="western"><surname>Dalgard</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Tambs</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Rognerud</surname><given-names>M</given-names></string-name>. <article-title>Measuring the mental health status of the Norwegian population: a comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36)</article-title>. <source><italic toggle="yes">Nord J Psychiatry</italic></source>. <year>2003</year>;<volume>57</volume>(<issue>2</issue>):<fpage>113</fpage>&#8211;<lpage>118</lpage>. doi:<pub-id pub-id-type="doi">10.1080/08039480310000932</pub-id><pub-id pub-id-type="pmid">12745773</pub-id></mixed-citation></ref><ref id="cit0086"><label>86.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Winhusen</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Kropp</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Babcock</surname><given-names>D</given-names></string-name>, et al. <article-title>Motivational enhancement therapy to improve treatment utilization and outcome in pregnant substance users</article-title>. <source><italic toggle="yes">J Subst Abuse Treat</italic></source>. <year>2008</year>;<volume>35</volume>(<issue>2</issue>):<fpage>161</fpage>&#8211;<lpage>173</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jsat.2007.09.006</pub-id><pub-id pub-id-type="pmid">18083322</pub-id><pub-id pub-id-type="pmcid">PMC2546520</pub-id></mixed-citation></ref><ref id="cit0087"><label>87.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Martino</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Paris</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Anez</surname><given-names>L</given-names></string-name>, et al. <article-title>The effectiveness and cost of clinical supervision for motivational interviewing: a randomized controlled trial</article-title>. <source><italic toggle="yes">J Subst Abuse Treat</italic></source>. <year>2016</year>;<volume>68</volume>:<fpage>11</fpage>&#8211;<lpage>23</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jsat.2016.04.005</pub-id><pub-id pub-id-type="pmid">27431042</pub-id><pub-id pub-id-type="pmcid">PMC4955716</pub-id></mixed-citation></ref><ref id="cit0088"><label>88.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Santa Ana</surname><given-names>EJ</given-names></string-name>, <string-name name-style="western"><surname>LaRowe</surname><given-names>SD</given-names></string-name>, <string-name name-style="western"><surname>Armeson</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Lamb</surname><given-names>KE</given-names></string-name>, <string-name name-style="western"><surname>Hartwell</surname><given-names>K</given-names></string-name>. <article-title>Impact of group motivational interviewing on enhancing treatment engagement for homeless veterans with nicotine dependence and other substance use disorders: a pilot investigation</article-title>. <source><italic toggle="yes">Am J Addict</italic></source>. <year>2016</year>;<volume>25</volume>(<issue>7</issue>):<fpage>533</fpage>&#8211;<lpage>541</lpage>. doi:<pub-id pub-id-type="doi">10.1111/ajad.12426</pub-id><pub-id pub-id-type="pmid">27589072</pub-id><pub-id pub-id-type="pmcid">PMC6082151</pub-id></mixed-citation></ref><ref id="cit0089"><label>89.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Smedslund</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Berg</surname><given-names>RC</given-names></string-name>, <string-name name-style="western"><surname>Hammerstrom</surname><given-names>KT</given-names></string-name>, et al. <article-title>Motivational interviewing for substance abuse</article-title>. <source><italic toggle="yes">Cochrane Database Syst Rev</italic></source>. <year>2011</year>;<volume>5</volume>:<fpage>CD008063</fpage>. doi:<pub-id pub-id-type="doi">10.1002/14651858.CD008063.pub2</pub-id><pub-id pub-id-type="pmcid">PMC8939890</pub-id><pub-id pub-id-type="pmid">21563163</pub-id></mixed-citation></ref><ref id="cit0090"><label>90.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Broome</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Joe</surname><given-names>GW</given-names></string-name>, <string-name name-style="western"><surname>Simpson</surname><given-names>DD</given-names></string-name>. <article-title>Engagement models for adolescents in DATOS-A</article-title>. <source><italic toggle="yes">J Adolesc Res</italic></source>. <year>2001</year>;<volume>16</volume>(<issue>6</issue>):<fpage>608</fpage>&#8211;<lpage>623</lpage>.</mixed-citation></ref><ref id="cit0091"><label>91.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Manetti</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Cavagnini</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Martino</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Ambrogio</surname><given-names>A</given-names></string-name>. <article-title>Effects of cocaine on the hypothalamic-pituitary-adrenal axis</article-title>. <source><italic toggle="yes">J Endocrinol Invest</italic></source>. <year>2014</year>;<volume>37</volume>(<issue>8</issue>):<fpage>701</fpage>&#8211;<lpage>708</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s40618-014-0091-8</pub-id><pub-id pub-id-type="pmid">24852417</pub-id></mixed-citation></ref><ref id="cit0092"><label>92.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Haney</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ward</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Gerra</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Foltin</surname><given-names>RW</given-names></string-name>. <article-title>Neuroendocrine effects of d-fenfluramine and bromocriptine following repeated smoked cocaine in humans</article-title>. <source><italic toggle="yes">Drug Alcohol Depend</italic></source>. <year>2001</year>;<volume>64</volume>(<issue>1</issue>):<fpage>63</fpage>&#8211;<lpage>73</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0376-8716(00)00232-5</pub-id><pub-id pub-id-type="pmid">11470342</pub-id></mixed-citation></ref><ref id="cit0093"><label>93.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Wemm</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Sinha</surname><given-names>R</given-names></string-name>. <article-title>Drug-induced stress responses and addiction risk and relapse</article-title>. <source><italic toggle="yes">Neurobiol Stress</italic></source>. <year>2019</year>;<volume>10</volume>:<fpage>100148</fpage>. doi:<pub-id pub-id-type="doi">10.1016/J.YNSTR.2019.100148</pub-id><pub-id pub-id-type="pmid">30937354</pub-id><pub-id pub-id-type="pmcid">PMC6430516</pub-id></mixed-citation></ref><ref id="cit0094"><label>94.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Aujla</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Martin-Fardon</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Weiss</surname><given-names>F</given-names></string-name>. <article-title>Rats with extended access to cocaine exhibit increased stress reactivity and sensitivity to the anxiolytic-like effects of the mGluR 2/3 agonist LY379268 during abstinence</article-title>. <source><italic toggle="yes">Neuropsychopharmacology</italic></source>. <year>2007</year>;<volume>33</volume>(<issue>8</issue>):<fpage>1818</fpage>&#8211;<lpage>1826</lpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.npp.1301588</pub-id><pub-id pub-id-type="pmid">17895914</pub-id></mixed-citation></ref><ref id="cit0095"><label>95.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kreek</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Koob</surname><given-names>GF</given-names></string-name>. <article-title>Drug dependence: stress and dysregulation of brain reward pathways</article-title>. <source><italic toggle="yes">Drug Alcohol Depend</italic></source>. <year>1998</year>;<volume>51</volume>(<issue>1&#8211;2</issue>):<fpage>23</fpage>&#8211;<lpage>47</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0376-8716(98</pub-id><pub-id pub-id-type="pmid">9716928</pub-id></mixed-citation></ref><ref id="cit0096"><label>96.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Koob</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Kreek</surname><given-names>MJ</given-names></string-name>. <article-title>Stress, dysregulation of drug reward pathways, and the transition to drug dependence</article-title>. <source><italic toggle="yes">Am J Psychiatry</italic></source>. <year>2007</year>;<volume>164</volume>(<issue>8</issue>):<fpage>1149</fpage>&#8211;<lpage>1159</lpage>. doi:<pub-id pub-id-type="doi">10.1176/APPI.AJP.2007.05030503/ASSET/IMAGES/LARGE/S16F7.JPEG</pub-id><pub-id pub-id-type="pmid">17671276</pub-id><pub-id pub-id-type="pmcid">PMC2837343</pub-id></mixed-citation></ref><ref id="cit0097"><label>97.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Booth</surname><given-names>BM</given-names></string-name>, <string-name name-style="western"><surname>Curran</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Han</surname><given-names>X</given-names></string-name>, et al. <article-title>Longitudinal relationship between psychological distress and multiple substance use: results from a three-year multisite natural-history study of rural stimulant users</article-title>. <source><italic toggle="yes">J Stud Alcohol Drugs</italic></source>. <year>2015</year>;<volume>71</volume>(<issue>2</issue>):<fpage>258</fpage>&#8211;<lpage>267</lpage>. doi:<pub-id pub-id-type="doi">10.15288/JSAD.2010.71.258</pub-id><pub-id pub-id-type="pmcid">PMC2841737</pub-id><pub-id pub-id-type="pmid">20230724</pub-id></mixed-citation></ref><ref id="cit0098"><label>98.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Ries</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Wolitzky-Taylor</surname><given-names>KB</given-names></string-name>, <string-name name-style="western"><surname>Operskalski</surname><given-names>JT</given-names></string-name>, <string-name name-style="western"><surname>Craske</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>Roy-Byrne</surname><given-names>P</given-names></string-name>. <article-title>Treatment of comorbid substance use and anxiety disorders: a case study</article-title>. <source><italic toggle="yes">J Addict Med</italic></source>. <year>2011</year>;<volume>5</volume>(<issue>4</issue>):<fpage>248</fpage>&#8211;<lpage>253</lpage>. doi:<pub-id pub-id-type="doi">10.1097/ADM.0b013e318233d64b</pub-id><pub-id pub-id-type="pmid">22042217</pub-id></mixed-citation></ref><ref id="cit0099"><label>99.</label><mixed-citation publication-type="book"><collab>Monitoring Centre for Drugs E, Addiction D</collab>. <article-title>Co-morbid substance use and mental disorders in Europe: a review of the data</article-title>. <source>EMCDDA Papers</source>. <publisher-loc>Luxembourg</publisher-loc>: <publisher-name>Publications office of the European Union</publisher-name>; <year>2013</year>. doi:<pub-id pub-id-type="doi">10.2810/725386</pub-id>.</mixed-citation></ref></ref-list></back></article></pmc-articleset>